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The human body is armed with defense mechanisms that combat 
microbial infections. The entry of microbes is detected by white 
blood cells, of which dendritic cells and macrophages are central 
innate effectors. The innate responses are induced upon microbial 
recognition, which is based on the detection of conserved microbial 
patterns by host cell receptors. This ultimately leads to the activation 
of multiple intracellular signaling pathways and the induction of 
host defense genes such as cytokines. 
In this study, we examined the activation of innate immune 
responses in response to the Salmonella bacterium or the Sendai 
virus. The results show that microbe-induced dendritic cells produce 
interleukins, chemokines, and interferons that may modulate the 
formation of adaptive immune responses. We also focused on the 
transcriptional regulation of selected cytokine genes and found 
similar patterns of regulation mechanisms requiring the concerted 
action of multiple transcription factors. This study reveals new data 
on how our immune system responds to microbes. 
ISBN 978-952-245-128-6
.!7BC5<2"HIEFLJ!
Taija Pietilä
Microbe-induced Innate 
Immune Responses in 
Human Dendritic Cells
National Institute for Health and Welfare
P.O. Box 30 (Mannerheimintie 166)
FI-00271 Helsinki, Finland
Telephone: +358 20 610 6000
www.thl.fi
RE
SE
AR
CH
RE
SE
AR
CH
Department of Vaccination
and Immune Protection
THL
RESEARCH 27 
Taija Pietilä 
 
 
Microbe-induced Innate Immune 
Responses in Human  
Dendritic Cells 
 
ACADEMIC DISSERTATION 
 
To be presented with the permission of the Faculty of Biological 
and Environmental Sciences, for public examination in the 
Arppeanum auditorium, Helsinki University Museum, 
Snellmaninkatu 3, Helsinki, on January 22nd, at 12 o’clock noon. 
 
 
 
 
Department of Vaccination and Immune Protection, National Institute for  
Health and Welfare, Helsinki, Finland 
and 
Department of Biosciences, Division of General Microbiology, University 
of Helsinki, Finland 
and 
Graduate School in Biotechnology and Molecular Biology,  
University of Helsinki, Finland 
 
Helsinki 2009 
THL  – Research 27/2009 2 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Author and National Institute for Health and Welfare 
 
 
 
ISBN 978-952-245-128-6 (printed) 
ISBN 978-952-245-208-5 (pdf) 
ISSN 1798-0054 (printed) 
ISSN 1798-0062 (pdf 
 
 
Helsinki University Print 
Helsinki, Finland 2009 
 
THL  – Research 27/2009 3 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
 
 
 
 
 
 
 
 
Supervised by  
Professor Ilkka Julkunen 
National Institute for Health and Welfare 
Helsinki, Finland 
  
Reviewed by  
Docent Kaisa Granfors 
National Institute for Health and Welfare 
Turku, Finland 
 
Docent Petteri Arstila 
University of Helsinki 
Helsinki, Finland 
  
Opponent 
Professor Thomas Decker 
University of Vienna 
Austria 
THL  – Research 27/2009 5 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
Abstract 
Taija Pietilä. Microbe-induced Innate Immune Responses in Human Dendritic Cells. 
National Institute for Health and Welfare (THL), Research 27/2009. 154 pages. 
Helsinki 2009. ISBN 978-952-245-128-6 (printed), ISBN 978-952-245-208-5 (pdf) 
 
Two types of antigen-presenting cells (APCs), macrophages and dendritic cells 
(DCs), function at the interface of innate and adaptive immunity. Through 
recognition of conserved microbial patterns, they are able to detect the invading 
pathogens. This leads to activation of signal transduction pathways that in turn 
induce gene expression of various molecules required for immune responses and 
eventually pathogen clearance. Cytokines are among the genes induced upon 
detection of microbes. They play an important role in regulating host immune 
responses during microbial infection. Chemotactic cytokines, chemokines, are 
involved in migratory events of immune cells. Cytokines also promote the 
differentiation of distinct T cell responses. Because of the multiple roles of 
cytokines in the immune system, the cytokine network needs to be tightly regulated. 
 
In this work, the induction of innate immune responses was studied using human 
primary macrophages or DCs as cell models. Salmonella enterica serovar 
Typhimurium served as a model for an intracellular bacterium, whereas Sendai virus 
was used in virus experiments. The starting point of this study was that DCs of 
mouse origin had recently been characterized as host cells for Salmonella. However, 
only little was known about the immune responses initiated in Salmonella-infected 
human DCs. Thus, cellular responses of macrophages and DCs, in particular the 
pattern of cytokine production, to Salmonella infection were compared.  
 
Salmonella-induced macrophages and DCs were found to produce multiple 
cytokines including interferon (IFN) -, which is conventionally produced by T and 
natural killer (NK) cells. Both macrophages and DCs also promoted the intracellular 
survival of the bacterium. Phenotypic maturation of DCs as characterized by up-
regulation of costimulatory and human leukocyte antigen (HLA) molecules, and 
production of CCL19 chemokine, were also detected upon infection with Salmonella. 
 
Another focus of this PhD work was to unravel the regulatory events controlling the 
expression of cytokine genes encoding for CCL19 and type III IFNs, which are 
central to DC biology. We found that the promoters of CCL19 and type III IFNs 
contain similar regulatory elements that bind nuclear factor B (NF-B) and 
interferon regulatory factors (IRFs), which could mediate transcriptional activation 
of the genes. The regulation of type III IFNs in virus infection resembled that of type 
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I IFNs – a cytokine class traditionally regarded as antiviral. The induction of type I 
and type III IFNs was also observed in response to bacterial infection.  
 
Taken together, this work identifies new details about the interaction of Salmonella 
with its phagocytic host cells of human origin. In addition, studies provide 
information on the regulatory events controlling the expression of CCL19 and the 
most recently identified IFN family genes, type III IFNgenes  
 
Keywords: Cytokines, dendritic cell, innate immunity, Salmonella, transcription 
factor 
 
 
THL  – Research 27/2009 7 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
Abstract in Finnish 
Taija Pietilä. Microbe-induced Innate Immune Responses in Human Dendritic Cells 
[Mikrobien aikaansaama synnynnäisen immuniteetin aktivoituminen ihmisen 
dendriittisoluissa]. National Institute for Health and Welfare (THL), Research 
27/2009. 154 pages. Helsinki 2009. ISBN 978-952-245-128-6 (printed),  
ISBN 978-952-245-208-5 (pdf) 
 
Kehomme immuunijärjestelmä on jakautunut synnynnäiseen ja hankittuun 
immuniteettiin, jotka yhdessä vastaavat mikrobi-infektioiden torjunnasta. 
Luonnollinen ja hankittu immuniteetti ovat vuorovaikutuksessa toistensa kanssa 
antigeeniä esittelevien solujen kuten makrofagien ja dendriittisolujen välityksellä. 
Makrofagit ja dendriittisolut tunnistavat evoluutiossa säilyneitä mikrobirakenteita, 
jotka toimivat varoitussignaalina puolustusjärjestelmien aktivoitumiselle. Eräs 
tärkeä ryhmä proteiineja, joiden tuotanto käynnistyy solunsisäisten 
signaalinvälitysreittien toimesta, ovat sytokiinit. Monet sytokiineistä ohjaavat T-
soluvasteiden erilaistumista, kemokiinien päätehtävänä on puolestaan säädellä 
valkosolujen liikennettä kudoksissa. Lukuisten tehtäviensä vuoksi on tärkeää, että 
sytokiinijärjestelmä on tiukan säätelyn alainen.  
 
Tässä työssä tutkittiin synnynnäisen immuniteetin aktivoitumista ihmisen 
makrofageissa ja dendriittisoluissa. Mikrobi-infektion mallintamisessa käytettiin 
Salmonella enterica sevorar Typhimurium -bakteeria sekä Sendai-virusta. Työ 
aloitettiin, koska haluttiin selvittää toimivatko ihmisen dendriittisolut Salmonella-
bakteerin isäntäsoluna, ja miten erityisesti sytokiinituotanto aktivoituu infektion 
aikana. Vertailukohtana käytettiin makrofageja, joiden toiminnasta Salmonella-
infektiossa tiedettiin jo paljon ennen tätä tutkimusta.  
 
Salmonella sai aikaan makrofageissa ja dendriittisoluissa useiden sytokiinien 
tuotannon mukaan lukien interferoni (IFN)-n, jota yleensä tuottavat luonnolliset 
tappajasolut ja T solut. Salmonella pystyi selviytymään paitsi makrofagien myös 
dendriittisolujen sisällä. Lisäksi CCL19-kemokiinin erittyminen ja tiettyjen 
antigeeniesittelyssä tarvittavien molekyylien ilmentyminen solun pinnalla kuvastivat 
dendriittisolujen kypsymistä Salmonella-infektion aikana.   
 
Tutkimuksessa tarkasteltiin myös tarkemmin miten sytokiinigeenien ilmentyminen 
on säädelty transkriptiotasolla. CCL19- ja tyypin III IFN -geenien 
promoottorialueilta löydettiin samankaltaisia säätelyelementtejä, joiden havaittiin 
sitovan NF-B- ja IRF-transkriptiotekijöitä välittäen myös geenien aktivaatiota. 
Osoitimme myös, että tyypin I ja tyypin III IFN -geenien säätely muistuttavat 
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toisiaan virusinfektiossa. Tyypin I ja III IFN -tuotantoa on aiemmin tutkittu 
pääasiallisesti virusinfektion aikana, mutta tuloksemme osoittavat, että niitä 
ilmennetään myös bakteeri-infektion seurauksena.  
 
Tämä väitöskirjatyö tuo esille uutta tietoa Salmonella-bakteerin ja sen isäntäsolujen, 
makrofagien ja dendriittisolujen, välisestä vuorovaikutuksesta. Lisäksi tutkimukset 
syventävät tietämystämme miten dendriittisolujen biologiassa tärkeiden CCL19- ja 
tyypin III IFN geenien aktivaatiota säädellään mikrobi-infektion aikana.   
 
Avainsanat: dendriittisolu,synnynnäinen immuniteetti,  Salmonella, sytokiini, 
transkriptiotekijä 
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Abbreviations 
AP-1 activator protein 1  
APC antigen-presenting cell  
ATCC American Type Culture Collection 
CARD caspase recruitment domain  
CARDIF CARD adaptor inducing IFN-
CD cluster of differentiation 
CHX cycloheximide 
DC dendritic cell 
ds double-stranded  
ELISA enzyme-linked immunosorbent assay 
FACS fluorescence-activated cell sorting 
FCS fetal calf serum 
GM-CSF granulocyte-macrophage colony stimulating factor 
HEK human embryonic kidney 
HLA human leukocyte antigen 
IFN interferon  
IKK inhibitory B kinase  
IL interleukin  
IRF interferon regulatory factor 
ISG IFN-stimulated gene  
ISGF3 interferon-stimulated gene factor 3   
ISRE interferon-stimulated response element 
JAK Janus kinase 
LPS lipopolysaccharide 
LTA lipoteichoic acid 
MAPK mitogen-activated protein kinase 
mDC myeloid dendritic cell 
MHC major histocompatibility class 
mo-DC monocyte-derived dendritic cell 
MOI multiplicity of infection 
MyD88 myeloid differentiation primary-response gene 88 
NF-B nuclear factor kappa-B 
NK natural killer  
NLR nucleotide-binding domain and leucine-rich repeat containing 
gene family 
NLRP3 NLR family, pyrin domain containing 3 
NOD nucleotide-binding oligomerization domain 
PAMP pathogen-associated molecular pattern 
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PBMC peripheral blood mononuclear cell 
pDC plasmacytoid dendritic cell 
PG peptidoglycan 
PRD positive regulatory domain 
PRR pattern recognition receptor 
RIG-I retinoic acid-inducible gene I 
RLR RIG-I-like receptor 
SDS sodium dodecyl sulphate 
SPI Salmonella pathogenicity island 
ss single-stranded  
STAT signal transducer and activator of transcription 
TBK1 Tank-binding kinase1 
Th T helper 
TIR Toll/IL-1 receptor 
TLR Toll-like receptor 
TNF tumor necrosis factor 
TRIF TIR domain-containing adaptor protein inducing IFN-
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1 Introduction 
Mammalian hosts are constantly in danger for the invasion of numerous pathogenic 
microbes. Although the host’s internal milieu is well protected by barriers such as 
skin and mucosal tissues, pathogens have evolved several strategies to circumvent 
such obstacles. Therefore, microbial infections must be limited by rigorous host 
defense mechanisms. 
 
The initial encounter between the host and the microbe rapidly activates innate 
immunity. The key players of this arm of immunity are complement, natural killer 
(NK) cells that destroy infected cells, as well as neutrophils, macrophages and 
dendritic cells (DCs), which actively take up microbes. The relatively non-specific 
activation of innate immunity depends on evolutionarily conserved pattern 
recognition receptors (PRRs) that are able to discriminate self from non-self 
structures.  
 
The omnipresent innate mechanisms are accompanied by activation of adaptive 
immunity, which provides efficient cytotoxic responses against the microbes as well 
as immunological memory and protective immunity. Unlike the innate responses, 
adaptive immunity is highly specific due to a vast repertoire of clonally selected 
receptors, and is activated in the late phase of infection. The generation of adaptive 
immune responses relies on the functions of T and B cells.  
 
The communication between the different types of immunity is primarily mediated 
by antigen presenting cells (APCs) including macrophages and DCs. In particular, 
DCs possess the capacity to prime naïve T cells. In response to infection, APCs also 
produce cytokines that, besides exerting direct antimicrobial functions, act as key 
messengers between immune effector cells. Cytokines regulate immune responses in 
multiple ways, thus their production needs to be firmly controlled when necessary.         
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2 Review of the literature 
2.1 Phagocytic, antigen-presenting cells of the immune 
system 
 
Phagocytosis, the uptake process of microbes and other large particles, represents 
one of the major mechanisms our innate immune system utilizes for fighting against 
pathogenic microbes. Professional phagocytes such as neutrophils, macrophages and 
DCs express phagocytic receptors for internalization of foreign particles including 
pathogens and apoptotic cells. However, only macrophages and DCs can efficiently 
act as APCs, and thereby contribute to the initiation of adaptive immune responses. 
2.1.1 Macrophages 
 
Macrophages are found in virtually all tissues. They differentiate from monocytes 
circulating in the peripheral blood. This monocyte cell population originates from a 
common myeloid progenitor cell in the bone marrow that is the precursor of many 
other cell types including neutrophils and DCs. Monocytes leave the blood 
circulation and enter different tissues where they display remarkable heterogeneity 
as macrophages in both functional and phenotypic aspects (1).  
 
Macrophages are vital both in maintaining tissue homeostasis through the clearance 
of apoptotic cells and tissue remodeling as well as activation of immune responses 
during microbial infections. The characteristic functional activities and set of surface 
receptors of a given macrophage population reflects the adaptation to different 
anatomical locations (1, 2). Kupffer cells in the liver, microglia of the central 
nervous system, and osteoclasts with bone resorption activity are all representatives 
of highly differentiated and specialized macrophage populations.  
 
Upon microbial infections, macrophages detect and internalize pathogens, and 
initiate T cell responses by antigen presentation (3). Macrophage receptors involved 
in immune recognition include cluster of differentiation (CD) 14, complement, 
scavenger and Fc-receptors, PRRs such as Toll-like receptors (TLRs), and lectins 
(4). Many of these receptors also mediate phagocytosis and trigger the activation of 
complex signaling cascades (5). 
 
Macrophages act primarily to destroy pathogens and are highly important in host 
defense to intracellular microbes. Their microbicidal activity is enhanced by 
cytokines, particularly interferon (IFN)-, produced by natural killer (NK) and T 
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cells. Consequently, macrophages themselves produce high levels of pro-
inflammatory mediators that influence the following immune response (1, 6).  
 
Intriguingly, some bacteria have evolved to survive the harsh intracellular milieu of 
macrophages. Listeria, Legionella, and Salmonella are good examples of such 
bacteria (5, 7).  
2.1.2 Dendritic cells  
 
DCs reside in peripheral tissues and lymphoid organs and sense the surrounding 
environment for invading microbes. This specialized cell has diverse origins; both 
myeloid and lymphoid progenitor cell lines can create different DC subtypes. In 
humans, myeloid DCs (mDCs) are found as Langerhans cells and interstitial DCs in 
the epidermal and dermal layers of the skin, respectively. Also secondary lymphoid 
organs and circulating blood contain subsets of mDCs. Plasmacytoid DCs (pDCs) of 
lymphoid origin travel in blood circulation (8). In mice, at least six different 
subtypes of DCs exist, although the precise definition of a subtype is still unclear (9). 
Conventional DCs can be subdivided based on the expression of lymphoid and 
myeloid lineage surface molecules or microenvironmental localization. pDCs and 
tumor necrosis factor (TNF) -/nitric oxide producing DCs are representatives of 
non-conventional mouse DCs (9, 10).   
 
The research of DC biology was for years hampered by the unavailability of in vitro 
cultivation techniques. The discovery that human monocytes could be differentiated 
into so-called monocyte-derived DCs (mo-DCs) in the presence of granulocyte-
macrophage colony stimulating factor (GM-CSF) and interleukin (IL)-4 (11), has 
led to a rapid accumulation of data on molecular and biological characteristics of 
DCs. The in vitro culture of human monocytes in the presence of GM-CSF alone 
yields monocyte-derived macrophages. Gene expression profiling has proven 
monocyte-derived macrophages and DCs to be quite different from one another (12). 
Although useful for studying DC biology, it remains unclear whether mo-DCs have 
counterparts in vivo (13).  
 
For detection of microbial components, DCs are armed with a wide repertoire of 
PRRs, the expression of which varies between different DC subtypes (8). Similar to 
macrophages, the cell surface of DCs is decorated with phagocytic receptors coupled 
to the internalization of pathogens (14, 15).  
 
Unique to DCs is that in order to be fully efficient APCs and thus capable of 
educating T cells, they must undergo a controlled maturation program. This is 
initiated upon DC contact with a microbe or inflammatory message from 
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environment. The process in general is characterized by morphological changes in 
cellular structure, down-modulation of endocytosis/phagocytosis, upregulation of 
costimulatory and MHC (human leukocyte antigen; HLA in humans) molecules, and 
secretion of cytokines (8, 14).  
 
DC maturation is often accompanied by migration of the cells from the periphery 
into secondary lymphoid tissues where antigen presentation takes place. DCs present 
endogenous and exogenous antigens in the context of MHC I and MHC II molecules, 
respectively (15). In addition, DCs are known to present exogenous antigens also by 
MCH I molecules, which is referred to as cross-presentation. Since DCs are the most 
efficient APCs, and they exclusively possess the ability to prime naïve T cells (both 
CD4+ and CD8+), they play a major role in initiating adaptive immune responses. In 
addition to inducing antigen-specific T cell responses, DCs can activate NK cells, 
natural killer T cells, and humoral responses in B cells (14, 16).  
 
The interaction of DCs and T cells involves a complex hierarchy of molecules. 
MHC molecules are first recognized by T cell receptor on antigen-specific T cells. 
This ‘signal one’ is not sufficient to activate immune responses. ‘Signal two’ 
constitutes the interaction of costimulatory molecules such as CD80 and CD86 on 
DCs with CD28 on T cells. ‘Signals one and two’ together promote immune 
responses, whereas signal one alone has been suggested to induce tolerance. ‘Signal 
three’ refers to the APC-derived mediators such as cytokines that direct the 
development of T cell responses into different types such as T helper (Th) 1 or Th2 
(17).  
 
Cytokines exhibit dual functions in the interaction of DC and T cells. On the one 
hand, pro-inflammatory cytokines and IFNs produced by innate immune cells 
modulate DC function and, on the other hand, cytokines secreted by DCs promote T 
cell differentiation. IL-12 produced by DCs favors Th1 type response important 
against intracellular pathogens (18, 19). Th17 cell-mediated immunity against 
extracellular bacteria and fungi require IL-23, another IL-12 family member 
produced by DCs. Th2-type responses essential against parasitic infections, and the 
induction regulatory T cells critical in maintaining tolerance, can also be promoted 
by DCs (19-21).  
 
Viruses, bacteria, and parasites have evolved several strategies to impede DC 
functions in host defense (8, 22). Many microbes actively block DC maturation, 
whereas some viruses induce apoptotic cell death in DCs.  Bacterial toxins delivered 
into the phagocyte can destroy DCs. Some pathogens exploit host cell receptors for 
their entry and thereby spread in the host. In contrast, some microbes inhibit the 
migration of DCs into the proximity of effector immune cells. A clever way to 
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exploit DCs is also the ability of microbes to switch from the protective cytokine 
responses to aberrant, non-protective type.  
 
Since DCs are central to multiple immune functions, the dysregulation of this finely 
controlled cell system poses several threats for human beings. DCs are implicated in 
autoimmune diseases such as systemic lupus erythematosus, multiple sclerosis and 
allergies. However, DCs can also be targeted in therapy and used as tools for 
vaccination (22).    
2.2 Innate pathogen recognition  
 
Activation of innate immune responses depends on rapid recognition of invading 
pathogens. Thus, innate immune cells including phagocytic macrophages and DCs 
are equipped with multiple receptor families that detect conserved microbial 
patterns, so called pathogen-associated molecular patterns (PAMPs) (Table 1). The 
PRRs detecting PAMPs can be divided into three major classes: TLRs, nucleotide-
binding and leucine-rich repeat containing gene family receptors (NLRs), and 
retinoic acid-inducible gene I (RIG-I) like receptors (RLRs) (Fig. 1.). TLRs, NLRs, 
and RLRs are not thought to directly mediate phagocytosis; in contrast, they 
determine the type of microbe and class of infection to control activation of adaptive 
immune responses. For this purpose, they activate intracellular signaling cascades 
resulting in the expression of many genes important in inflammatory and immune 
responses.  
 
2.2.1 Toll-like receptors 
 
Mammalian immune system comprises at least 12 TLR members, out of which 
TLRs 1-10 have been identified in humans (23, 24). The importance of the TLR 
system in innate immunity was originally discovered in Drosophila, when Lemaitre 
and co-workers showed that the Toll protein played a major role in antifungal 
defenses (25). Afterwards, the specific pathogen ligands for most TLRs have been 
found (Table 1.), and for some interacting receptor-ligand pairs even crystal 
structures have been determined (23).  
 
TLR molecules are type I transmembrane proteins that contain leucine-rich repeat 
and Toll/IL-1 receptor (TIR) domains for recognition of PAMPs and initiation of 
intracellular signaling, respectively. TLRs can be classified according to their 
cellular location. TLRs 1, 2, 4, 5, 6, and 11 are expressed on the cell surface, 
whereas TLRs 3, 7, 8, and 9 are found in intracellular locations such as endosomes 
or lysosomes (23, 24). TLR expression in general is ubiquitous among immune cells, 
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and can be modulated in response to pathogens, cytokines, and stress factors. 
However, the distinct set of TLRs in blood mDCs and pDCs is an example reflecting 
the specialization of these cell types to respond to certain stimuli (26, 27).  
 
Bacteria are recognized by a wide repertoire of TLRs. Defective responses to 
lipopolysaccharide (LPS) in mice strains carrying mutations in the Tlr4 gene led to 
the discovery of TLR4 (28). LPS is the major component of the cell wall in Gram-
negative bacteria and responsible for the septic shock. TLR2 is involved in the 
detection of peptidoglycan (PG), lipoproteins and lipoteichoic acid, and is 
considered more important in immune responses against Gram-positive bacteria. 
TLR2 can interact with TLR1, TLR6, and non-TLR molecules to discriminate the 
molecular properties of the ligands (23, 29, 30). Extracellular flagellin, a structural 
component of bacterial motility apparatus, is detected by TLR5 (31-33). TLR11 has 
been implicated in the recognition of uropathogenic bacteria (34), but the human 
ortholog is nonfunctional.  
 
The genomic material of bacteria is recognized via TLR7 and TLR9. The presence 
of unmethylated CpG motifs in prokaryotic DNA was originally described as the 
basis for TLR9 operation (35). Later it has been shown that the phosphodiester 2’ 
deoxyribose backbone of single-stranded (ss) DNA is sufficient to confer TLR9 
activation (36) and that the discrimination between self and non-self DNA is feasible 
due to the endosomal localization of TLR9 (37). Recent work by Mancuso et al. (38) 
has demonstrated that bacterial RNA can be sensed by TLR7 in conventional DCs. 
Similar role for TLR7 in recognition of bacterial RNA has been suggested in pDCs 
(39). Thus, all known TLRs except TLRs 3, 8, and 10 have reported functions in the 
recognition of bacterial ligands. 
 
The genomic material of viruses also serves as the major target for TLR family 
members. TLR3 detects double-stranded (ds) RNA (40), TLRs 7 and 8 sense ssRNA 
(41, 42), and TLR9 recognizes the genetic material of some DNA viruses (43). In 
addition, TLRs 2 and 4 have been implicated in detection of proteins and unknown 
ligands of viral origin (23). 
 
TLR signaling is mediated via multiple adaptor molecules including myeloid 
differentiation primary response gene 88 (MyD88), TIR domain-containing adaptor, 
TIR domain-containing adaptor protein inducing IFN- (TRIF), and TRIF-related 
adaptor molecule (Fig. 1.). After ligand binding, the TIR domains of TLRs and 
adaptors interact, and the activation of distinct signaling pathways follows. MyD88 
is utilized by all other TLRs except TLR3, whose sole adaptor is TRIF. MyD88 
signaling platform involves the recruitment of multiple protein kinases including IL-
1 receptor-associated kinases, TNF receptor-associated factors, and transforming 
growth  factor  –activated  kinase 1.  The  signaling  events lead to the activation of  
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Table 1. PRRs and their bacteria/virus –derived PAMPs  
 
  
PRR 
 
PAMPs 
Origin of 
the ligand 
Site of 
recognition 
TLR TLR1-TLR2 triacyl lipopeptides bacteria cell surface 
 TLR2-TLR6 diacyl lipopeptides 
lipoteichoic acid 
mycobacteria 
bacteria 
cell surface 
 TLR2 peptidoglycan 
lipoarabinomannan 
bacteria 
mycobacteria 
cell surface 
 TLR3 dsRNA RNA viruses endosomes 
 TLR4 lipopolysaccharide 
envelope proteins 
bacteria 
viruses 
cell surface 
 TLR5 flagellin bacteria cell surface 
 TLR7 ssRNA 
RNA 
viruses 
bacteria 
endosomes 
 human TLR8 ssRNA viruses endosomes 
 TLR9 CpG DNA 
DNA  
bacteria 
DNA viruses 
endosomes 
 murine TLR11 unknown uropathogenic 
bacteria 
cell surface 
RLR LGP2 RNA viruses cytosol 
 MDA-5 RNA viruses cytosol 
 RIG-I RNA viruses cytosol 
NLR NAIP5 flagellin bacteria cytosol 
 NLRC4 flagellin bacteria cytosol 
 NLRP1 anthrax lethal toxin bacteria cytosol 
 NLRP3 muramyl dipeptide 
RNA 
toxins 
bacteria 
bacteria, viruses 
bacteria 
cytosol 
 NOD1 diaminopimelic 
acid  
bacteria cytosol 
 NOD2 muramyl dipeptide 
ssRNA 
bacteria 
viruses 
cytosol 
Others AIM2 dsDNA viruses, bacteria cytosol 
 DAI dsDNA viruses, bacteria cytosol 
 
Abbreviations: AIM2, absent in melanoma 2; DAI, DNA-dependent activator of IRFs; LGP2, laboratory of 
genetics and physiology 2; MDA5, melanoma differentiation-associated gene 5; NAIP5, neuronal apoptosis 
inhibitory protein 5; NOD, nucleotide-binding oligomerization domain; NLR, nucleotide-binding and leucine-
rich repeat containing gene family receptor; NLRC, NLR family, CARD domain containing; NLRP, NLR 
family, pyrin domain containing; PAMP, pathogen-associated molecular pattern; PRR, pathogen recognition 
receptor; RIG-I, retinoic acid-inducible gene I; RLR, RIG-I-like receptor; TLR, Toll-like receptor 
Adapted from (23, 24, 38, 45-48) 
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NF-B and mitogen-activated protein kinases (MAPKs). TRIF in association with 
TLR3 or TLR4 complex triggers an alternative pathway whereby interferon 
regulatory factors (IRFs), in addition to NF-B, are activated. Consequently, the 
activation of transcription factors important in the induction of cytokine genes is 
elicited in the host cell (23, 44). 
2.2.2 Cytoplasmic surveillance 
 
NLR family of intracellular receptors is composed of at least 23 members in humans, 
while 34 NLR-encoding genes exist in the mouse genome. All NLRs have three 
domains: an N-terminal protein interaction domain, a central nucleotide binding 
domain, and a C-terminal leucine-rich repeat domain (49). NLRs sense a wide range 
of microbial PAMPs (Table 1.) and endogenous ‘danger’ signals. Nucleotide-
binding oligomerization domain (NOD) 1 and NOD2 are among the best 
characterized NLR family members, which detect structural motifs of PG. NOD1 
senses meso-diaminopimelic acid commonly found in Gram-negative and certain 
Gram-positive bacteria, whereas NOD2 detects muramyl dipeptide structure of PG 
abundantly present both in Gram-negative and Gram-positive bacteria (50, 51). 
Signaling pathways of NOD proteins culminate in the activation of NF-B and 
MAPKs (51). This results in the transcriptional upregulation of pro-inflammatory 
cytokine and host defense genes.  
 
In contrast, upon detection of specific microbial motifs, some NLRs assemble a 
molecular scaffold termed inflammasome composed of caspase-1 and several 
adaptor molecules. NLR family, CARD domain containing 4 and neuronal apoptosis 
inhibitory protein 5 act as sensors for intracellular flagellin (24, 32). NLR family, 
pyrin domain containing 3 (NLRP3) has been implicated in the detection of bacterial 
and viral ligands such as derivatives of PG and RNA, as well as endogenous 
molecules (52, 53). In addition, NLR family, pyrin domain containing 1 detects 
bacterial toxins (24). These different types of inflammasomes share a common 
feature: they recruit caspase-1, which promotes processing of  pro-IL-1 and pro-IL-
18 resulting in the secretion of bioactive cytokines (50).  
 
Interestingly, recent studies have documented the inflammasome activation by a 
non-NLR receptor absent in melanoma 2, which binds dsDNA by virtue of its 
HIN200 domain (46-48). Cytosolic dsDNA can also be recognized by DNA 
dependent activator of IRFs (54), but the biological role of this receptor needs 
further investigation. The repertoire of nucleic acid sensors is still likely to expand 
in future.  
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Three members of RLRs, retinoic acid inducible gene I (RIG-I), melanoma 
differentiation-associated gene 5, and laboratory of genetics and physiology 2, 
specialize in cytoplasmic detection of viral RNA (Table 1.). The receptors bear 
RNA-helicase domains for detection of RNA and tandem caspase activation and 
recruitment domains (CARDs) for downstream signaling, but laboratory of genetics 
and physiology 2 receptor lacks CARDs (55). Work by Yoneyama et al. (56) 
showed that RIG-I lacking CARDs or carrying a mutation in the adenosine 
triphosphate-binding site of the helicase domain exhibits dominant negative activity. 
However, RIG-I construct devoid of the helicase domain could induce constitutive 
downstream signaling, which isa useful property for studying gene activation. After 
the revelation of RLRs, the interacting adaptor molecule was simultaneously found 
by four different laboratories, and thus four different names were given to the same 
molecule (57-60). CARDIF used here stands for CARD adaptor inducing IFN-
CARDIF localizes to the mitochondria, and mediates signaling to activate NF-B 
and IRFs. 

Thus, signaling of cytoplasmic detector molecules converges with TLRs on NF-B 
and MAPKs, while the activation of IRFs has remained the property of TLRs and 
RLRs, but not NLRs (Fig. 1). Intriguingly, two reports have now implicated NOD2 
in the activation of IRFs and production of type I IFNs (45, 61). It is likely that more 
such examples exist because the signaling cascades and cooperation of different 
pathways are only beginning to be understood. Furthermore, the discovery of novel 
PRRs, especially those of sensing cytoplasmic nucleic acids, will enlighten the 
current view of pathogen recognition.  
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2.3 Cytokines 
 
Cytokines are soluble mediators of the immune system that act in autocrine or 
paracrine fashion as opposed to hormones that have endocrine effects. Cytokines 
often target several cell types exerting multiple actions, which is referred to as 
pleiotropy. Moreover, structurally unrelated cytokines can induce similar effects in 
target cells, thus, redundancy is another characteristic of the cytokine system. 
Properties of some cytokines are also antagonism or synergism, where two or more 
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cytokines can inhibit each others function, or act together so that the end result 
differs qualitatively from that seen with individual cytokines, respectively (62). 
 
Cytokines include IL, IFN, chemokine, colony-stimulating factor, TNF, 
transforming growth factor , and growth factor families (62). During microbial 
infection, panoply of cytokines is released to combat infection. Classical pro-
inflammatory cytokines TNF-, IL-1, and IL-6 are rapidly produced by many cell 
types in response to microbial infection. Some cytokines with chemotactic 
properties (chemokines) produced by macrophages and DCs attract other effector 
cells to the site of infection/inflammation or direct T cell responses thus bridging 
innate and adaptive immunity. In addition to pro-inflammatory effects, cytokines 
secreted by phagocytic APCs direct the generation of Th responses. Despite the 
crucial role of cytokines in resistance to microbial infections, over-production of 
them may be detrimental to the host. Therefore, the elaborate cytokine system must 
be tightly regulated.       
2.3.1 Cytokines inducing Th1 immunity 
 
Cytokines act as master regulators of immune responses by inducing appropriate Th 
cell polarization against different types of microbes. Specifically, effective 
immunity against intracellular bacterial infections requires the differentiation of Th1 
cells. The key cytokines regulating Th1 immune responses are IL-12, IFNs and IL-
18 (63).  
 
The natural source of IL-12 during microbial infection is the phagocytic cell 
population. This heterodimeric cytokine consists of p40 and p35 subunits. The IL-12 
receptor, composed of two chains – IL-12R1 and IL-12R2 – is mainly found on 
the cell surface of activated T cells, NK cells, but to some extent also on DCs and 
macrophages. IL-12 induces the production of IFN- by T cells and NK cells, which 
further activates antimicrobial activities in phagocytes. IFN- is the prototypic 
cytokine produced by cells of the Th1 lineage (18, 63, 64).  
 
The biology of IL-12 is intertwined with that of another IL-12 family member IL-23, 
as they share the p40 subunit (65), and the IL-12R1 chain of the receptor complex 
(66). Unique components of the IL-23 cytokine system include p19 subunit (65) and 
IL-23R (66) for the cytokine and its receptor, respectively. Like IL-12, IL-23 is 
predominantly produced by phagocytic cells in response to infection and is 
important in innate immunity. However, instead of inducing Th1 responses, IL-23 
appears to play a role in memory T cell responses and in survival and maintenance 
of Th17 subset (19, 64).   
 
 THL  – Research 27/2009 26 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
Animal studies in mice have established the role of IL-12, IL-23, and IFN- in 
resistance to many infections, particularly against intracellular bacteria. This is also 
true in humans, as patients with inherited human immunodeficiencies that affect the 
IL-12/IL-23–IFN- axis due to mutations in genes encoding the cytokine, its 
receptor, or signaling components, suffer from recurrent infections caused by 
weakly pathogenic mycobacteria and Salmonella species (64, 67-71).  
 
APC-derived IL-12 induces Th1 cells and enhances their IFN- production. This can 
be augmented by function of other cytokines such as IL-18, which is also produced 
by APCs. IL-12 together with IL-18 increases IFN- production by Th1 (72, 73) and 
NK cells (74). More efficient IFN-production can also be mediated by synergism 
between IL-18 and IFN-(75, 76). The synergism between cytokines is likely to 
play a role in enhanced IFN- production also in macrophages and DCs, which are 
not regarded as conventional producers of this cytokine (77, 78).  
 
IL-18 is constantly present in macrophages and DCs as pro-IL-18 form, which is 
cleaved into biologically active IL-18 by caspase-1. The secretion of mature IL-18 
(and IL-1) is the hallmark of inflammasome activation. IL-18 plays a major role in 
innate immune responses to pathogens, particularly against intracellular bacteria, 
whose elimination requires the induction of IFN-(50, 79).   
 
2.3.2 Chemokines 
 
The chemokine superfamily with about 50 members in humans can be grouped 
according to the arrangement of four cysteines in their sequence. Most chemokines 
fall into the category of CC or CXC classes, in which the cysteines are adjacent or 
separated with one amino acid, respectively. C and CX3C classes consist of only 
three chemokines. The G protein-coupled receptors that bind to specific chemokine 
classes have been named accordingly: CCR1-10 bind CC chemokines, CXCR1-5 
bind CXC chemokines, XCR1 binds the only C chemokine lymphotactin, and 
CX3CR1 binds CX3C chemokines (80-82).  
 
Chemokines and their receptors have a myriad of biological functions including 
lymphoid organ development, cell recruitment both in homeostasis and 
inflammation, and development of Th1/Th2 responses. Some functions are shared 
by many chemokines, whereas others are more specific. This is partly explained by 
the promiscuity of binding between some chemokine receptors and ligands (80, 81).        
 
Chemokines can be functionally divided into inflammatory and homeostatic groups. 
Inflammatory chemokines produced during infection recruit effector cells to the 
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inflammation site and often promote a Th1 cytokine expression profile. Homeostatic 
chemokines, in contrast, are constitutively produced in various organs including 
bone marrow, thymus, and secondary lymphoid organs in the absence of apparent 
infection. Nevertheless, some chemokines may exhibit both inflammatory and 
homeostatic functions (80).  
 
Chemokines and their receptor system are closely linked to functions of DCs and 
many recent discoveries in chemokine research have been made in this field. The 
ability of DCs to switch the pattern of chemokine and chemokine receptor 
expression during maturation process has been characterized in detail. In a 
simplified model, immature DCs produce inflammatory chemokines such as CCL5, 
CXCL10, and CCL20 rapidly in response to infection (83, 84). In addition, they 
respond to these chemokines via expression of respective receptors. The interaction 
between CCL20 and its receptor CCR6 on the surface of DCs is considered 
particularly important for guiding immature DCs to the infection site (83, 84). 
Moreover, increased secretion of CCL5 and CXCL10 attracts activated memory T 
cells (85). At later times of infection, DCs coordinately lose their responsiveness to 
inflammatory chemokines due to the loss of cognate receptor expression while up-
regulating the expression of CCR7 (83, 84, 86). This chemokine receptor has two 
ligands, CCL21 and CCL19, which both attract naïve T cells (87, 88). Mature, but 
not immature, DCs secrete CCL19 (83, 84), and it has been shown that CCR7 and its 
ligands play crucial roles in directing mature DCs into T cell zones of lymph nodes, 
and recruitment of naïve T cells into the vicinity of DCs (83, 89-91).  
 
2.3.3 Interferons 
 
IFNs were originally discovered due to their ability to inhibit viral replication. Three 
classes of IFNs, based on the receptor complex they use for signaling, are found in 
humans: type I, type II, and type III IFNs. Signal transduction by all IFNs is 
mediated via the activation of Janus kinase (JAK) – signal transducer and activator 
of transcription (STAT) pathway. Previously, only the role of type II IFN was 
intensively studied in bacterial infections, and the possible role of other IFNs in anti-
bacterial immunity is only beginning to be fully acknowledged.  
 
Type I IFNs 
 
Human genome contains genes for IFN-, IFN-, IFN-, IFN-, and IFN-ω. IFN- 
subtypes are encoded by 13 functional genes, whereas all other type I IFNs are 
represented by a single gene. The major subtypes produced during infection are 
IFN- and IFN-. Type I IFNs utilize a receptor consisting of IFNAR1 and IFNAR2 
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chains, and the signal transduction eventually results in the induction of several 
hundred IFN-stimulated genes (ISGs) (92-94). 
 
The promoters of type I IFN genes contain multiple regulatory domains that function 
as binding sites for transcription factors. In the case of IFN-, these are named as 
positive regulatory domains (PRDs). PRD-I and PRD-III bind IRF family members, 
whereas PRD-II and PRD-IV are specific for NF-B and activator protein 1 (AP-1), 
respectively. The promoters of IFN-genes lack NF-B sites. Upon virus infection, 
PRDs are known to direct the coordinated recruitment of transcription factors to 
assemble an IFN- enhanceosome (95, 96).  
 
Virtually all cells can produce type I IFNs, but the professional cell type secreting 
vast amounts of type I IFNs particularly in viral infections was identified to be pDC 
(97, 98). The ability of pDCs to produce high levels of type I IFN is partly due to 
their strong expression of TLR7 and 9 (27). In other cells, stimulation of TLR3- and 
TLR4-dependent pathways (utilizing TRIF) may result in type I IFN production (99).  
 
Moreover, TLR-independent systems such as RLRs (56, 100), DNA-dependent 
activator of IRFs (54), and yet unidentified intracellular sensors can trigger the 
induction of type I IFNs (101-110). Many of these and other studies have confirmed 
that also bacterial infection can lead to a robust type I IFN response (38, 101, 103-
112). In the search of novel immunoreceptors capable of activating type I IFN 
response, new bacterial ligands are also being discovered. An example is the 
bacterial second messenger cyclic-di-guanosine monophosphate that induces type I 
IFNs via activation of IRFs, NF-B, and MAPKs (102).  
 
With the exception of pDCs, host cells use an amplification loop strategy to increase 
the amount of type I IFN. IFN- and in certain cells, IFN-4, are synthesized 
rapidly in response to infection. The small amount of secreted IFN binds to the 
IFNAR on the cell surface and this autocrine action stimulates the synthesis of more 
IFN- and other IFN- subtypes (113, 114). This feedback loop seems highly 
important in defense against viral infections. Moreover, evidence from in vitro 
studies suggests that similar positive feedback system operates in Listeria 
monocytogenes-infected macrophages (108, 115) and Mycobacterium tuberculosis-
infected DCs (112).    
 
The TLR4-TRIF-dependent signaling in response to LPS stimulation leads to the 
production of type I IFNs, IFN- representing the major subtype. A subset of genes 
regulated by LPS stimulation appears to be dependent on type I IFNs. Interestingly, 
mice deficient in IFN- production show resistance to LPS-induced endotoxin shock 
(92, 116, 117). Thus, type I IFNs produced in response to LPS has important effects 
on the immune system. Moreover, type I IFNs can trigger DC 
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differentiation/activation as well as influence DC-mediated T cell responses. It is 
therefore evident that type I IFNs produced during infection provides a critical link 
between innate and adaptive immune responses (118, 119).  
 
Interestingly, the role of type I IFNs in bacterial infection is multifaceted. They can 
confer protective effects as is the case in Salmonella enterica serovar Typhimurium 
(120) or Legionella pneumophila (103, 121) infection. Type I IFNs are also crucial 
in host resistance against Gram-positive group B streptococci and pneumococci 
(122). In Gram-positive Listeria monocytogenes infection, however, the production 
of type I IFNs is detrimental to the host (115, 123). 
 
Type II IFN 
 
Type II IFN or IFN- shows no amino acid identity to other IFNs. IFN- signaling is 
transmitted via IFN- receptor composed of IFNGR1 and IFNGR2 chains. During 
infection, the major source of this IFN type is activated T cells and NK cells. IFN- 
acts mainly on macrophages by inducing several antibacterial target genes such as 
inducible nitric oxide synthase and nicotinamide adenine dinucleotide phosphate-
oxidase, which have direct bactericidal effects in cells (92-94).  
 
Interestingly, emerging evidence has demonstrated that IFN- can also be secreted 
by macrophages and DCs (77, 78, 124-126). Most of these studies used different 
combinations of cytokines or TLR ligands, but reports using live bacteria such as 
Listeria (126) and mycobacteria (124) have revealed the importance of APC-
secreted IFN- during bacterial infections.   
 
Type III IFN 
 
Human type III IFN or IFN-family consists of IFN-1, IFN-2, and IFN-3 
(synonyms include IL-29, IL-28A, and IL-28B, respectively) (127, 128). The murine 
type III IFN system differs from that of humans in the respect that only IFN-2 and 
IFN-3 are functional. The gene encoding for IFN-1 is a pseudogene in the mouse 
(129). Type III IFNs mediate their antiviral effects via signaling through a receptor 
complex composed of IL10R2 and IFNLR1 chains (127, 128). Despite the use of 
different receptor complex, type I and type III IFNs both activate the formation of 
interferon stimulated response gene factor 3 (ISGF3), composed of STAT1, STAT2, 
and IRF9, as well as STAT1 homodimers recognizing IFN- activated sequences 
(127, 129, 130) (Fig. 2). Consequently, the gene expression profile triggered by type 
I and type III IFNs appears to be practically uniform (131).  
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Stimulation of mo-DCs with TLR3/TLR4 agonists or viral infection leads to type III 
IFN expression (99, 132). In pDCs, type III IFNs are induced upon TLR9 activation 
(99). In monocyte-derived macrophages, the efficient activation of type III 
IFNgenes in response to TLR3 or TLR4 stimulation requires IFN- priming (133). 
The generation of mice deficient in IFNLR1 has suggested a specific role of type III 
IFNs in TLR3- or TLR9-activated antiviral activity. This study did not find a 
significant role for IFN-s in resistance against a number of pathogenic viruses 
(134). By contrast, another study that used IFNLR1 knock-out mice in Mx1+/+ 
background concluded that type III IFNs are important in host resistance against 
pulmonary influenza A but not hepatotropic virus infection (135).  
 
Unlike the ubiquitously expressed IFNAR, the receptor for type III IFNs displays 
more restricted expression pattern. The cellular response to type III IFNs is 
determined by the expression of the IFNLR1 subunit unique to type III IFN 
signaling (131, 136, 137). In addition to epithelial cells, human blood DCs as well as 
in vitro cultured monocyte-derived macrophages and DCs express high levels of 
IFNLR1(130, 136).   
 
Like type I IFNs, type III IFNs have been shown to possess immunomodulatory 
functions some of which have been described in the human system. In particular, 
IFN-1 activates human monocytes/macrophages to produce cytokines (138) and 
down-regulates Th2-responses initiated by DCs by modulating cytokine secretion 
(139). When compared to IFN-, IFN-1-treated DCs displayed only a partially 
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matured phenotype and were shown to specifically induce the proliferation of 
suppressor T cells expressing Foxp3 (136).  
2.3.4 Transcriptional control of cytokine gene regulation 
 
The rapid innate immune response following microbial attack requires that the 
changes in gene expression are tightly regulated. The most profound regulation of 
cytokine genes occurs at the transcriptional level. The diversity of transcription 
factors that operates in gene regulatory networks of immune system is enormous. 
Here, three classes of transcription factors – IRFs, NF-B, and MAPK activated AP-
1 – are described and outlined in the context of type I IFN gene induction. These 
transcription factors form an integral part of the enhanceosome, a multiprotein 
complex that directs the transcription of IFN-gene.  
 
IRFs 
 
The IRF family of transcription factors comprises nine members. All IRFs contain a 
conserved DNA binding region that recognizes a consensus DNA sequence termed 
IFN-stimulated response element (ISRE). They associate with other transcription 
factors and co-activators the combinations of which vary according to the specific 
stimulus and determine the outcome of gene expression. Although it is now clear 
that IRFs are involved in many regulatory events in innate and adaptive immunity, 
their role is perhaps most carefully characterized in the context of type I IFN gene 
induction (95, 140, 141).  
 
Multiple IRFs participate in the induction of type I IFN genes (95, 140, 141). 
However, IRF3 and IRF7 seem to play key roles at least in viral infection (96). IRF3 
is constitutively expressed in cells and upon viral infection, becomes phosphorylated, 
and is transported into the nucleus (142). Phosphorylated IRF3 can form 
homodimers or it may heterodimerize with IRF7, and in association with co-
activators, IRF dimers bind their target DNA sequence. Two protein kinases, Tank-
binding kinase 1 (TBK1) and inhibitory B kinase () , phosphorylate and 
thereby activate IRF3 and IRF7 (143, 144). IRF7 is present only in small amounts in 
the absence of infection (with the exception of pDCs). The increased expression of 
IRF7 depends on formation of ISGF3 complex that is activated in positive feedback 
phase of type I IFN signaling (113). The ISGF3 complex consists of STAT1, 
STAT2, and IRF9, and activates ISGs by binding to ISRE sequence (141).  
 
It was previously thought that IRF3 is responsible for the initial activation of IFN- 
gene, whereas IRF7 participates in the induction of IFN- genes in later phases of 
virus infection (113, 114). However, experiments in virus-infected Irf7-/- mice 
 THL  – Research 27/2009 32 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
demonstrated that IRF7 plays a crucial role in the induction of both IFN- and IFN-
 genes, while IRF3 is likely to have a less important role (145). However, IRF3 
may be more important in the activation of other cytokine genes such as CXCL10 
(117, 146). In addition, if LPS is used to stimulate type I IFNs, IRF3 rules over IRF7 
(117, 145).  
 
The first IRF identified, IRF1, was shown to positively regulate IFN- transcription 
in original studies (141). However, the findings that the IFN- enhanceosome did 
not contain IRF1 (96), and that Irf1-/- mice had intact type I IFN induction in virus-
infected fibroblasts argued against this (141). Recently, IRF1 has been ascribed a 
more specific role in TLR-mediated signaling that is functional in myeloid DCs. 
When induced by IFN-, IRF1 could interact with MyD88, and in collaboration with 
NF-B, mediated the induction of IFN- among other genes (147).  
 
Viral infection or TLR7/8 stimulation mimicking virus infection have also been 
shown to activate IRF5 and thereby contribute to the induction of type I IFNs (148-
150). Afterwards, IRF5 was reported to activate the expression of pro-inflammatory 
cytokines, but not that of type I IFNs, via TLR-dependent pathways (151). Therefore, 
the role of IRF5 in type I IFN induction needs further investigation.   
 
In contrast to other cell types, pDCs constitutively express high levels of IRF7 (152).  
It has been shown that pDCs depend on IRF7 for induction of type I IFNs. Moreover, 
IRF7 interacting with MyD88 retains TLR-ligands in endosomal vesicles for 
prolonged IFN expression (145, 153, 154). Interestingly, DC-specific mode of type I 
IFN induction is further governed by IRF8 (155, 156). The stimulatory role of IRF8 
in transcription IFN genes was specifically required for the feedback phase of 
induction (156). 
 
The differential activation of IRFs and their contribution to the induction of type I 
IFN genes during bacterial infection is far less studied. The most commonly 
reported IRF to be responsible for IFN activation in bacteria-infected cells is IRF3 
(101, 103, 106-108, 110, 112). IRF1 has been implicated in TLR7-dependent 
bacteria-induced IFN production in conventional DCs, but not in pDCs or 
macrophages (38). Interestingly, a study performed in human DCs infected with 
Mycobacterium tuberculosis provided correlative evidence for the role of IRF7 (in 
addition to IRF3) in the expression of type I IFN genes (112). Very recently, 
Mycobacterium tuberculosis-induced IFN induction was depicted to employ IRF5, 
but not IRF3 or IRF7, in mouse cells (61). Similar contrasting results have been 
reported from Listeria monocytogenes-infected mouse (108, 115) or human cells 
(157). The two former studies described IRF3 and IRF7 to be important in type I 
IFN induction, whereas the latter found no role for IRFs. These discrepancies imply 
that the differential activation of IRFs can be species-specific.  
 THL  – Research 27/2009 33 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
NF-B 
 
The mammalian NF-B family includes five members: p65/RelA, p50, RelB, p52, 
and c-Rel. The Rel homology domain of these proteins mediates binding to DNA, 
dimerization, and interaction with IB proteins. Formation of different homo- or 
heterodimers determines target gene specificity as different NF-B sites display 
selectivity in NF-B dimer usage. Among NF-B partners, p50 and p52 lack a 
transactivation domain; thus homodimers of p50 or p52 are mainly repressors of 
transcription. The prototypical NF-B complex is composed of p50 and p65. This 
heterodimer is activated via the classical pathway, which enables a multiprotein IKK 
complex to trigger the phosphorylation of IB proteins. In steady state, NF-B is 
kept inactive in the cytoplasm by IB proteins. Only upon stimulus, IB is degraded 
and NF-B translocates into the nucleus. By contrast, the alternative NF-B 
signaling pathway results in the formation of RelB-p52 heterodimers. This pathway 
involves a different IKK complex, and is activated only by few ligands unlike the 
promiscuously induced classical pathway (158-160).  
 
NF-B is involved in the transcription of many cytokine genes including IFN-. 
Together with IRFs and other co-activators, NF-B (p50/p65) is part of the IFN- 
enhanceosome (96, 161). In the case of IFN-, each transcription factor class binds 
onto its respective site in the promoter region. However, NF-B p65 and IRF3 can 
also directly interact and function as each others’ co-activators for the transcription 
of IRF- or NF-B-dependent genes (162, 163).  
 
MAPKs 
 
Three major MAPK cascades operate in mammalian cells: the p38 MAPK, the 
extracellular signal-regulated protein kinases (ERK), and the c-Jun NH2-terminal 
kinases (JNK) (Fig. 3.). MAPKs are activated via phosphorylation by upstream 
kinases that in turn are activated in response to various extracellular stimuli such as 
stress, growth factors, and cytokines. MAPKs themselves phosphorylate several 
downstream molecules including kinases and transcription factors, and hence affect 
the gene expression (164, 165).  
 
The MAPK activated transcription factors such as AP-1 are involved in the 
regulation of many cytokine genes. The dimeric AP-1 is composed of members of 
Jun and Fos families, and binds to AP-1 sites present on target genes (166). For IFN-
 gene transcription, AP-1 heterodimer of c-Jun and ATF2 is recruited to the IFN- 
enhanceosome upon virus infection (95, 96).  
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2.4 Salmonella  
2.4.1 Overview of Salmonella pathogenesis 
 
Salmonella enterica serovar Typhimurium (S. typhimurium) is a common cause of 
gastroenteritis in humans. However, in mice the same bacterium manifests an illness 
resembling human typhoid fever, a systemic disease caused by Salmonella enterica 
serovars Typhi or Paratyphi. Thus, S. typhimurium-infected mice provide a model 
for studying systemic Salmonella infections. Salmonella gastroenteritis infections 
are usually self-limited in humans and the symptoms include fever, cramping, and 
diarrhea. In rare cases, bacteremia may develop and lead to severe complications. 
Subsequent to the actual intestinal salmonellosis, Salmonella, among other enteric 
bacteria, can also trigger an acute inflammatory joint disease called reactive arthritis 
(167-169).  
 
As a food- and water-borne pathogen, Salmonella must traverse the intestinal 
epithelium to exit the lumen of intestine. This occurs via several routes including 
penetration of M cells or epithelial cells, and capture of bacteria by DCs. Once 
across the intestinal epithelium, Salmonella interacts with macrophages and DCs 
which take up the bacteria. Bacteria can also disseminate to mesenteric lymph nodes 
and other lymphoid sites or reach the blood stream through transportation within 
phagocytic cells (10, 168). 
 
To resist the defense activities of the host, Salmonella has evolved several virulence 
mechanisms. Salmonella pathogenicity islands (SPIs) encode type III secretion 
systems that deliver virulence factors into the host cell. SPI-1 is activated when 
Salmonella is invading epithelial cells, whereas SPI-2-encoded virulence effectors 
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are required for the intracellular survival of Salmonella inside phagocytes. Moreover, 
the activity of PhoP/PhoQ, a two-component system, is necessary for the survival of 
bacteria in the harsh milieu of phagocytes (168).  
 
2.4.2 Interaction of Salmonella with phagocytes 
 
Historically, Salmonella was considered an facultative intracellular pathogen of 
macrophages. With the advent of specific tools for phenotypic characterization and 
culture techniques for DCs, it was demonstrated that also DCs are important havens 
for Salmonella. Salmonella faces its phagocytic hosts once traversed the epithelial 
cell lining after which murine DCs present in Peyer’s patches can take up 
Salmonella (10, 170). Alternatively, CD18-expessing phagocytes provide 
Salmonella a route to bypass the obstacle formed by the epithelium. They can 
transport Salmonella from the gastrointestinal tract to the bloodstream and seed 
lymphoid sites (10, 171). In addition, Rescigno et al. (172) have described a 
mechanism through which DCs could capture invasion-deficient Salmonella from 
the lumen of the gut while maintaining the integrity of the epithelium. More recently, 
a DC subset expressing the chemokine receptor CX3CR1 was found to sample 
intestinal microbiota, including Salmonella, from the gut lumen (173).  
 
To invade non-phagocytic cells, Salmonella induces its own entry via injecting SPI-
1 encoded effectors into the cellular cytosol. These bacterial proteins promote 
polymerization of the actin cytoskeleton and formation of macropinocytic 
membrane extensions, which results in bacterial internalization (174). Phagocytic 
macrophages and DCs have an inherent ability to take up microbes via phagocytic 
receptors. The uptake routes of Salmonella in macrophages depend either on the 
host cell receptors such as complement or Fc receptors or Salmonella-induced 
invasion factors encoded by SPI-1 (175). However, the virulence genes important 
for the entry of Salmonella in macrophages are not required in DCs (176).  
Salmonella-mediated endocytosis in macrophages resembles macropinocytosis, a 
form of endocytosis allowing the internalization of fluid-phase solute inside large 
vesicles. Macropinocytosis is dependent on actin polymerization and is found 
constitutively active in immature DCs. Chemicals that block actin polymerization 
inhibit both phagocytosis and macropinocytosis, and therefore inhibit bacterial 
internalization (168, 177, 178).    
 
The interaction of Salmonella and the phagocyte leads to the formation of a 
specialized vacuole called Salmonella containing vacuole (SCV) (179), which 
protects the bacteria from antibacterial activities of the host. The vacuolar 
compartment and SPI-2-encoded effectors inhibit the fusion of Salmonella-
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containing phagosomes with lysosomes (180, 181). In addition to macrophages, the 
intracellular survival of Salmonella is promoted in murine DCs (170, 176, 182, 183). 
Interestingly, Salmonella strains attenuated in survival within macrophages can still 
persist in DCs (176, 182). Moreover, although phagocytes actively induce 
antibacterial defense mechanisms, there is evidence that Salmonella kills DCs 
involving host caspase-1 activation (184, 185), a phenomenon first observed in 
macrophages (186).  
 
Salmonella also exploits the migratory capacity of phagocytes to establish a 
systemic infection. CD18-expressing phagocytes can transport bacteria into the liver 
and spleen (171). Intestinal lamina propria DCs that sense Salmonella flagellin are 
suggested to contribute to systemic infection as they transport bacteria preferably to 
mesenteric lymph nodes (33). In vitro and in vivo evidence implies that migration of 
Salmonella- containing DCs depends on the chemokine receptor CCR7 and its 
ligands CCL19 and CCL21 (187, 188). On the other hand, this migratory event is 
required for the induction of T cell responses by DCs. Indeed, it is now evident that 
DCs are highly important in generation of anti-Salmonella immunity (10).  
2.5 Sendai virus 
 
Sendai virus or murine parainfluenza type I belongs to the genus Respirovirus of the 
family Paramyxoviridae. It is considered non-pathogenic in humans, but causes 
severe respiratory infections in mice. The virus particle is enveloped and contains 
the genetic material as negative-stranded ssRNA. The virus genome is composed of 
the nucleocapside, phospho-, matrix, fusion, haemagglutinin-neuraminidase, and 
large protein genes (189, 190).     
 
Many intracellular signaling cascades such as TLR- and RLR-dependent pathways 
are activated in Sendai virus-infected cells. The replication of Sendai virus occurs in 
the cytoplasm, and the dsRNA formed in the replicative stage serves as a major 
PAMP recognized by intracellular PRRs. Sendai virus induces an efficient antiviral 
response including type I IFN production making Sendai virus an excellent tool to 
study the activation of innate immune mechanisms in molecular detail (132, 190, 
191).  
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3 Aims of the study 
Cytokines play an important role in regulating host immune responses during 
infection. The starting point of this study was that DCs of mouse origin had recently 
been characterized as host cells for S. typhimurium. However, only little was known 
about the immune responses initiated in Salmonella-infected DCs. Thus, cellular 
responses of macrophages and DCs, in particular the pattern of cytokine production, 
to S. typhimurium were compared. Another focus of this work was to unravel the 
regulatory events controlling the expression of cytokine genes of CCL19 and type 
III IFNs in human DCs.  
 
The specific objectives of this study were: 
 
1. To analyze the activation of immune responses in S. typhimurium –infected DCs 
using macrophages as a reference point. 
 
2. To characterize the requirements for transcriptional induction of CCL19 gene in S. 
typhimurium –infected DCs. 
 
3. To study the regulation of most recently identified IFN family genes, type III IFN, 
and compare their induction with those of type I IFN genes. 
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4 Material and methods 
4.1 Cell culture 
 
4.1.1 Monocyte-derived macrophages and dendritic cells (I-IV) 
 
Leukocyte-rich buffy coats were obtained from Finnish Red Cross Blood 
Transfusion Service. To minimize inter-individual variation, each experiment was 
performed with cells of three to four donors, which were pooled upon collection in 
majority of cases to obtain enough material for RNA and protein studies. Peripheral 
blood mononuclear cell (PBMC) population was first separated by Ficoll 
(Amersham Biosciences) gradient centrifugation. The mononuclear cell layer was 
collected and washed with PBS.  
 
For macrophage differentiation, monocytes were allowed to adhere onto cell culture 
plates (1 h at +37C), and non-adherent cells were removed with thorough washing 
with PBS. Macrophages were cultured in serum-free macrophage medium (Gibco) 
supplemented with antibiotics (penicillin 0.6 g/ml, streptomycin 60 g/ml) and 10 
ng/ml GM-CSF. The medium was replaced every two days. After six to seven days 
of culture, macrophages were fully differentiated and used in experiments and the 
medium was replaced to RPMI-1640 (Sigma-Aldrich) supplemented with antibiotics, 
2 mM L-glutamine, 20 mM HEPES, and 10% fetal calf serum (FCS; Integro). 
 
For DC differentiation, monocytes were further purified by Percoll (Amersham 
Biosciences) gradient centrifugation and magnetic depletion of contaminating T and 
B cells. Monocytes were then allowed to adhere onto cell culture plates (1 h at 
+37C), and non-adherent cells were removed with thorough washing with PBS. 
DCs were cultured in RPMI-1640 medium supplemented with antibiotics, 2 mM L-
glutamine, 20 mM HEPES, 10% FCS, 10 ng/ml GM-CSF, and 20 ng/ml IL-4. Fresh 
medium was added every two days. DCs were used in experiments after 6-7 days of 
culture.  
 
4.1.2 Cell lines (II,IV) 
 
The human embryonic kidney (HEK)-293 cell line (American Type Culture 
Collection; ATCC CLR1573) was maintained in continuous growth in Eagle-MEM 
(Sigma-Aldrich) supplemented with antibiotics, L-glutamine, and 10% FCS.  
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4.2 Microbes 
 
4.2.1. Salmonella enterica serovar Typhimurium (I-III) 
 
Salmonella enterica serovar Typhimurium ATCC 14028 strain was stored in the 
presence of 15% glycerol at -70C. S. typhimurium was inoculated onto Luria agar 
and grown overnight at 37C. One colony was inoculated in Luria broth and grown 
overnight at 37C with shaking. The culture was then diluted 1:100 in Luria broth 
and grown for 2.5 h as above to obtain bacteria in a logarithmic growth-phase. 
Bacteria were collected by centrifugation and washed with PBS. The multiplicity of 
infection (MOI) was adjusted by reading the culture density at the optical density of 
600 nm. The MOI was confirmed by plating serial dilutions onto Luria plates.   
 
4.2.2. Streptococcus thermophilus (III) 
 
Streptococcus thermophilus was obtained from Valio research centre (Helsinki, 
Finland) and stored in skimmed milk at -70C. S. thermophilus was inoculated  onto 
M17 agar (Lab M, Topley House) supplemented with 20 g/L D (+) lactose 
monohydrate (J.T. Baker B.V.) and grown overnight at 37C. One colony was 
inoculated in M17 broth (Difco) containing 20 g/L lactose and grown overnight. S. 
thermophilus was further passaged by 1:30 dilution to fresh M17 broth containing 
lactose. After 17 h of culture, bacteria were in late logarithmic growth phase. The 
desired amount of bacteria was collected by centrifugation. The number of bacteria 
was determined microscopically in Petroff-Hauser chamber or by plating serial 
dilutions onto M17 agar plates for viable count calculation.   
 
4.2.3. Sendai virus (II-IV) 
 
Sendai virus (Cantell strain) was cultured in embryonated chicken eggs and used 
from stocks stored at -70C. The hemagglutination titer of Sendai was 4096 and the 
infectivity of the stock in DCs was 6x109 pfu/ml.  
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4.3 Reagents  
 
4.3.1 Purified cytokines and antibodies (I, II, and unpublished) 
 
The experimental use of purified human cytokines and neutralizing cytokine-
specific antibodies raised in animals is outlined in Table 2.   
 
Table 2. Cytokines and antibodies used in this study  
 
 Concentration used Reference/Source Used in  
Purified cytokines    
IFN- 100 IU/ml Finnish Red Cross  I 
IFN- 100 IU/ml Schering-Plough unpublished 
IFN- 100 IU/ml Finnish Red Cross I 
IFN- 10 ng/ml ZymoGenetics unpublished 
IL-1 10 ng/ml R&D Systems II 
IL-12 10 ng/ml R&D Systems I 
IL-18 30 ng/ml Biosite I 
TNF- 5-10 ng/ml R&D Systems I, II 
Antibodies    
anti-IFN- 1200 neutralizing U/ml (192) I 
anti-IFN- 80 neutralizing U/ml (192) I 
anti-IL-12 1 g/ml R&D Systems I 
anti-IL-18 1:200 dilution of antisera (193) I 
 
4.3.2. TLR ligands (I, III) 
 
S. typhimurium ATCC 14028 smooth LPS (TLR4 agonist) preparation was from 
Sigma. Purified FliC, flagellin protein (TLR5 agonist) purified from S. typhimurium 
ATCC 14028, was purchased from Alexis Biochemicals.  
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4.3.3. Pharmacological inhibitors (II, III) 
 
Commercial inhibitors were used to inhibit cellular processes as specified in Table 3.  
 
Table 3. Chemically synthesized inhibitors used in this study  
 
 Concentration used Cellular target  Used in  
Cell signaling inhibitors     
DEM1 5, 20, or 100 M NF-B  II 
PDTC1 5, 20, or 100 M NF-B  II, IV 
PD980592 50 M ERK MAPK  II, IV 
SB2021902 10 M p38 MAPK  II, IV 
SP6001251 10 M JNK MAPK  IV 
Ly2940022 50 M PI3K  IV 
CsA1 1 g/ml NFAT  II 
Other inhibitors     
CHX3 30 g/ml de novo protein synthesis  IV 
dynasore3 20-120 M dynamin (194)  IV 
 
Abbreviations: CHX, cycloheximide; CsA, cyclosporin A; DEM, diethyl maleate; PDTC, pyrrolidine 
dithiocarbamate; PI3K, phosphoinositide 3-kinase;  NFAT; nuclear factor of activated T cells  
Purchased from 1Alexis Biochemicals, 2Calbiochem, 3Sigma 
 
4.4 mRNA expression analysis 
 
4.4.1 Northern blot analysis (I, II, IV) 
 
Total cellular RNA was isolated by the guanidium isothiocyanate/cesium chloride 
method (I) or by using an RNA purification kit (Qiagen; II, IV). Samples containing 
equal amounts (10 g) of RNA were size-fractionated on 1% formaldehyde-agarose 
gels and transferred onto Hybond-N nylon membranes (Amersham Biosciences). 
Membranes were hybridized with cDNA probes labeled with -32P-adenosine 
triphosphate (3000 Ci/mmol, Amersham Biosciences) by random priming. The 
membranes were hybridized in Ultrahyb buffer (Ambion), washed in 1 x saline 
sodium citrate/0.1% sodium dodecyl sulphate (SDS), and exposed to Kodak films at 
-70C with intensifying screens. To control equal RNA loading, ribosomal RNA 
was visualized with ethidium bromide staining, or membranes were hybridized with 
a -actin probe.   
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4.4.2 Quantitative RT-PCR (III, IV) 
 
Total cellular RNA was isolated by using an RNA purification kit (Qiagen) 
including DNase I treatment. RNA was synthesized into cDNA by TaqMan Reverse 
Transcriptase kit (Applied Biosystems). The cDNA samples were then amplified in 
TaqMan Universal PCR master mix buffer (Applied Biosystems) using commercial 
gene expression assay mix oligonucleotides from Applied Biosystems. The data was 
normalized to housekeeping -actin gene (III) or 18S rRNA (IV).  
 
4.5 Protein analyses  
 
4.5.1 Cytokine-ELISA assays (I, II, III) 
 
Cell culture supernatants of different donors were kept separate and stored at -20C.  
Cytokine levels from cell culture supernatants were analyzed by antibody pairs and 
standards from BD Pharmingen, R&D Biosystems, Biosite, and PBL Biomedical 
Laboratories as indicated in the original publications. All the procedures are based 
on sandwich enzyme-linked immunosorbent assay (ELISA). IL-12 and IL-10 
cytokine measurements presented in 5.1.4 as unpublished data were performed using 
FlowCytomix bead assay by Bender MedSystems.   
 
4.5.2 Western blotting (II-IV) 
 
Protein lysates were stored at -70C in the presence of 0.5 mM DTT, 1 mM Na3Vo4, 
and a protease inhibitor mixture. Equal amounts of whole cells or nuclear extracts 
were separated on SDS- polyacrylamide gel electrophoresis using the Laemmli 
buffer system. Proteins were transferred onto Immobilon-P membranes (Millipore). 
Detailed information about the antibodies used for immunoblotting can be found in 
the Material and Methods section of the original publications. The protein bands 
were visualized using the enhanced chemiluminescence system (Amersham 
Biosciences).   
 
4.5.3 Flow cytometry (I, III) 
 
Cells were collected as pooled or donor-separated, washed with PBS, and fixed with 
paraformaldehyde for 15 min. The cells were stored in 2% FCS/PBS at 4C. The 
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expression of cell surface markers on DCs was analyzed using FITC- or PE- 
conjugated antibodies and appropriate isotype controls. Samples were analyzed with 
FACScan or FACS Canto II flow cytometer and analyzed with Cell Quest or FACS 
Diva software, respectively, all provided by Becton Dickinson.  
 
4.6 Transcription factor binding analyses 
 
4.6.1 In silico analyses (II, IV) 
 
Promoter regions of human CCL19 and IFN-1-3 were analyzed for transcription 
factor binding sites using freely available softwares such as Vector NTI Suite 
(Invitrogen), MatInspector (Genomatix), and Transcription Element Search System 
(http://www.cbil.upenn.edu/cgi-bin/tess/tess). The searches were focused on putative 
NF-B or ISRE/PRD sites that could potentially bind NF-B or IRFs, respectively.  
4.6.2 DNA affinity binding method (II, IV) 
 
Synthesized biotinylated DNA oligonucleotides containing the putative transcription 
factor binding site in the middle were ordered from DNA technology. Equal 
amounts of nuclear extracts were incubated for 2 h at 4C with streptavidin-agarose 
beads (Pierce) coupled to annealed oligonucleotides. After washing of unbound 
proteins, the oligonucleotide-bound proteins were released in SDS sample buffer 
and boiled. Equal aliquots were run on SDS-polyacrylamide gel electrophoresis gels 
and analyzed by Western blotting.  
 
4.7 Transfections (II, IV) 
 
HEK-293 cells were seeded at optimal confluence one day prior to transfection. The 
reporter and expression plasmids were introduced into HEK-293 cells with 
FuGENE6 (Roche; II) or TransIT (Mirus; IV) reagent. Renilla luciferase plasmid 
was used to control transfection efficiency. Total amount of DNA was adjusted with 
an empty expression vector. In some experiments, cells were infected with Sendai 
virus. Luciferase reporter assays were performed with a Dual Glo kit (Promega) 
according to manufacturer’s instructions and luminescence was detected with Victor 
multilabel reader (Wallac).  
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4.8 Gentamicin protection assay (I, III) 
 
Prior to infection, monocyte-derived macrophages and DCs were cultured for 2 h in 
antibiotic-free RPMI-1640 medium supplemented with glutamine, HEPES, and 10% 
FCS. In some experiments, cells had been pre-treated with IFN- and/or TNF-for 
16 h (I). Dynasore used in IV was added to cells 10 min before infection. Cells were 
infected with logarithmic growth phase S. typhimurium at a MOI of ~1. Infection 
was allowed to last 1 h, after which non-internalized bacteria were killed with 100 
g/ml gentamicin-containing medium for additional 1 h. The bacterial uptake was 
determined at 2 h, whereas for later time points studying the intracellular fate of 
bacteria, the cells were maintained in the medium containing 20 g/ml gentamicin. 
The number of intracellular bacteria was determined at various time points; after 
thorough washing with PBS, host cells were lysed with 0.2% Triton-X-100 and 
bacteria released from cell interiors were cultured onto Luria agar to assess colony 
forming units.  
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5 Results and discussion 
5.1 Interaction of S. typhimurium with human APCs 
5.1.1 Uptake and intracellular survival of S. typhimurium (I) 
 
The ability of Salmonella to survive and replicate within phagocytes is an important 
premise for systemic infection and involves the activation of SPI2-encoded effectors 
(168). When this study was commenced, reports had addressed the intracellular 
survival of Salmonella in murine DCs (170, 176, 182, 183). Furthermore, Dreher et 
al. (195) had demonstrated the intracellular persistence of Salmonella in human DCs.  
 
We compared the efficiency of bacterial uptake and the ability of S. typhimurium to 
survive in human monocyte-derived macrophages and DCs. Using gentamicin 
protection assay, bacterial uptake was determined as the percentage of inoculated 
bacteria surviving antibiotic treatment. In addition, the intracellular fate of bacteria 
was followed at various time points. Bacterial uptake by macrophages and DCs 
occurred at a similar range (2-3% of inoculated bacteria) (Fig. 6 in I, top graphs). In 
contrast to macrophages, viable counts of Salmonella in DCs showed a gradual 
decline already during the first 24 h. Neither cell type could completely eliminate 
the bacteria during the three-day follow-up (Fig. 6 in I, second graphs from top). 
 
Dreher et al. (195) reported that human DCs harboring S. typhimurium for prolonged 
periods of time (beyond 24 h infection) were shown to undergo extensive apoptosis 
or necrosis thus interfering with quantification of intracellular bacteria. However, in 
that particular study cells were infected with MOI of 25, while we used MOI 1 in 
our experiments to avoid bacteria-induced cytotoxicity. The magnitude of 
Salmonella-induced host cell death correlates with the MOI used and represents one 
strategy the bacterium uses against host defenses (184-186).     
 
Next, we analyzed whether antimicrobial activities and thus intracellular killing of 
bacteria could be induced by pre-treatment of cells with IFN-, TNF-, or their 
combination (196, 197). In our model setting, cytokine pre-treatment did not seem to 
affect bacterial killing (Fig. 6 in I, three bottom graphs). By contrast, cytokine pre-
treatment decreased bacterial uptake when compared to cells without priming (Fig. 6 
in I, top graphs). This was most pronounced in DCs treated with IFN- and TNF-
cytokines that will induce maturation of DCs resulting in decreased endocytosis 
capacity. Contrary to our results, Rescigno et al. (183) showed that IFN- pre-
treatment enhances killing of Salmonella particularly in bone marrow-derived 
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macrophages. This could simply indicate differences between cells of human and 
mouse origin responding to Salmonella infection.    
 
5.1.2 Production of pro-inflammatory and Th1 type cytokines (I) 
 
During bacterial infection, phagocytic APCs act at the interface of innate and 
adaptive immunity. The key regulators of immune responses are cytokines – their 
production modulates the outcome of the immune response and is crucial for the 
host to resist microbial infections. Early work had demonstrated that besides 
macrophages, also DCs respond to Salmonella infection with the production of 
cytokines (178, 182, 198). In particular, Salmonella-infected murine DCs were 
reported to produce TNF-, IL-1, IL-6, and IL-12 (178, 182, 198). Besides studies 
by Dreher et al. (184, 195), which reported TNF-, IL-10, IL-12, and IL-18 
production in Salmonella-infected human mo-DCs, only limited data on the 
interaction of Salmonella with DCs of human origin was available.    
 
Therefore, we considered it important to compare Salmonella-induced cytokine 
production in human macrophages and DCs. To study this, we stimulated monocyte-
derived macrophages and DCs with S. typhimurium and detected cytokine 
expression at mRNA or protein level. Both cell types induced the expression of 
TNF-, IL-12 p35, IL-12 p40, IL-18, and IFN-genes (Fig. 2 in I). In accordance 
with results by Dreher et al. (184, 195), we also detected the production of TNF-, 
IL-12 (p70 form), and IL-18, albeit the level of IL-18 in DCs was modest as 
compared to macrophages (Fig. 3B in I). IL-12, IL-18, and IFN- are known to favor 
the induction of Th1 responses that are effective against intracellular pathogens such 
as S. typhimurium (18, 64, 199).  
 
An interesting novel observation was that IFN- protein accumulated in the cell 
supernatants of Salmonella-infected macrophages and DCs at late times of infection 
(24 and 48 h). This suggested its production to be regulated by other cytokines. As 
IL-18 together with IL-12 or type I IFNs is known to induce synergistic production 
of IFN- in NK and T cells (72-76), the conventional producers of this type of IFN, 
we tested whether IFN- production in macrophages and DCs was dependent on 
other Th1 type cytokines. By using neutralizing antibodies against IFN-/, IL-12, 
and IL-18 in different combinations, a significant decrease in IFN- production by 
Salmonella-infected macrophages was seen when all the tree antibodies were 
combined (Fig. 4A in I). In DCs, however, anti-IL-18 alone or combined with anti-
IL-12 could significantly reduce IFN- production (Fig. 4A in I). Consistently, when 
cells were stimulated with purified IFN-, IL-12, or IL-18 preparations, 
macrophages required all three cytokines for efficient IFN- production. In DCs, 
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instead, the addition of IL-12 and IL-18 was sufficient for maximal IFN- 
production (Fig. 4B in I). We concluded that in DCs, the contribution of IL-12 and 
IL-18 to IFN- production is more important than in macrophages. It remains 
possible, however, that other cytokine-dependent or –independent mechanisms are 
involved in regulation of IFN- production in this experimental setting, as IFN- 
levels produced in response to bacteria were at least ten-fold higher as compared 
with the levels obtained with cytokine stimulations (Figs 3B and 4B in I). 
 
As mentioned above, DCs or macrophages were not considered typical sources of 
IFN-, although reports with such findings existed before ours (77, 78, 125, 126). Of 
note, later work in our laboratory has shown that mo-DCs can induce the production 
of IFN- even in response to Gram-positive, probiotic bacteria (200). Thus, DCs can 
respond to bacterial infection by producing IFN-and this is not restricted to 
infection with S. typhimurium. This early source of IFN- by DCs and macrophages 
is believed to facilitate the innate responses against microbes prior to adaptive T 
cell-mediated immunity. IFN- produced in autocrine prime loop by myeloid cells 
increases their production of IFN- and IL-12, which serve as signals for Th1 cell 
differentiation (63).    
5.1.3 Production of chemokines (I, II) 
 
Chemokines are classified as cytokines that have chemotactic properties and thus are 
involved in regulating cellular traffic. At the time this study was initiated, no data on 
Salmonella-induced chemokine expression in human DCs were available. We 
compared the induction of CCL5, CCL19, CCL20, and CXCL10 genes in 
Salmonella-stimulated macrophages and DCs. The major finding from the Northern 
blot and ELISA data (Figs 2 and 3A in I) was the preferential production of CCL19 
or CCL20 by DCs or macrophages, respectively.  
 
Upon maturation, DCs are known to modulate the expression of chemokines such as 
CCL19 and CCL20, and their cognate receptors (83, 84, 86). Furthermore, the 
interplay of CCL19 and its receptor CCR7 is crucial for the migration of DCs into 
the lymph nodes as well as for the recruitment of naïve T cells into the vicinity of 
activated DCs (83, 87-91), which leads to the initiation of adaptive immune 
responses. Although not investigated by us, it is reasonable to assume that CCL19 
plays an important role in the biology of Salmonella infection. Upon up-regulation 
of CCR7, mature DCs containing Salmonella have been reported to migrate towards 
CCL19 and CCL21 in vitro (187). Moreover, in an adoptive transfer model, 
transportation of Salmonella to the lymph nodes occurred within DCs but not 
macrophages (188).    
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Again, the production of CCL19 was not exclusive to Salmonella infection as 
increased levels of this chemokine were also detected in response to infection with 
Sendai virus (Fig. 1 in II). In an attempt to recapitulate the production of CCL19 
with addition of purified cytokines (Fig. 6 in II), we noted that live bacteria were 
superior inducers of CCL19 compared to stimulation with cytokines or Sendai virus.    
 
5.1.4 Phenotypic maturation of DCs (I, III) 
 
Transformation of an antigen-capturing DC into an efficient APC is collectively 
referred to as DC maturation. The modulation of cell surface molecules to enable 
antigen presentation and interaction of DCs with T cells is one of the major events in 
the process (14-16), and can be easily detected.  
 
Mo-DCs were infected with increasing doses of Salmonella, and the expression of 
CD80, CD83, CD86, and HLA-II was determined by flow cytometric analysis. 
Compared to unstimulated cells, infected DCs showed up-regulated levels of all the 
studied molecules (Fig. 1 in I). Even the lowest bacteria/host cell ratio (0.3:1) 
sufficed at inducing the up-regulation of these marker proteins. Furthermore, up-
regulation of CD86 was detected also in response to Salmonella-derived LPS and 
flagellin, ligands of TLR4 and TLR5, respectively (Fig. 5A in I). Previously, it had 
been observed that murine DCs infected with Salmonella up-regulate several co-
stimulatory and MHC class I and II molecules leading to the presentation of 
Salmonella-encoded antigens to T cells (176, 178, 183, 198).  The up-regulation of 
CD86 had been described in S. typhimurium -infected human DCs (195) and also in 
accordance with our results, flagellin and LPS had been shown to induce the 
expression of CD80, CD83, CD86, and HLA-II (201). We and others also observed 
that although flagellin was able to induce the expression of maturation markers, 
flagellin-stimulated DCs did not produce cytokines such as IL-12 or CXCL10 (Fig. 
5 in I) (201, 202). This indicates that there are clear qualitative differences between 
TLR4- and TLR5-induced signaling.    
 
Salmonella-induced maturation was also analyzed in the context of signaling to type 
II IFNs (see section 5.1.5). To block dynamin-dependent endocytosis (194) and thus 
bacterial uptake (Fig. 6 in III), we pre-treated DCs with dynasore and then analyzed 
the expression of CD86 and HLA-II. Dynasore-treated, Salmonella-infected DCs 
were impaired in the expression of CD86 and HLA-II compared to mock-treated 
infected cells (Fig. 4A in III). Similar results were obtained when DCs were 
stimulated with LPS (data not shown). In general, bacterial uptake is not required for 
phenotypic maturation of DCs. In reference to Salmonella-infected DCs, the up-
regulation of CD86 and MHC II in the murine cell model does not require bacterial 
 THL  – Research 27/2009 49 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
uptake (203). In the present time, we are unable to provide a definitive explanation 
for these contrasting results. Dynasore has been reported to inhibit the TRAM-TRIF 
signaling in LPS-stimulated murine macrophages (204). In addition, TRIF is 
required for maximal LPS-induced maturation of murine DCs (205). It is therefore 
reasonable to speculate that dynasore reduces the expression of CD86 and HLA-II 
due to interference with TRIF signaling also in human DCs. 
5.1.5 Induction of type I and type III IFNs (I, III) 
 
Production of type I IFNs is a hallmark of innate immune responses directed not 
only against viral infections, but also other classes of pathogens (92-94). Bacteria- 
and virus-induced IFN synthesis share many characteristics, but the analysis of IFNs 
in bacterial infection is especially warranted by the fact that they seem to exert 
variable effects on the host immune responses (92).  
 
We chose to analyze the induction of type I IFNs in monocyte-derived macrophages 
and DCs infected with S. typhimurium. We detected a transient IFN- expression 
pattern in our Northern blot analysis (Fig. 2 in I) that seemed to be stronger in 
macrophages. Later, with a more sensitive quantitative RT-PCR technique, we 
found that the expression of IFN- was, in fact, induced more efficiently in DCs 
(Fig. 1A in III and data not shown). The responses to whole bacteria or TLR4 ligand 
LPS were inseparable. Consistent with previous results by Coccia et al. (99), IFN- 
subtypes were induced only weakly (Fig. 1A in III and data not shown). 
 
In a previous report, TLR4 stimulation of DCs induced not only a transient induction 
of IFN-, but also that of type III IFNs (99). This prompted us to analyze the 
expression of recently discovered IFN- family members in bacteria-infected cells. 
Indeed, stimulation of DCs with S. typhimurium or TLR4 ligand LPS led to the 
induction of IFN-1 and IFN-2/3 mRNAs (Fig. 1A in III). Human IFN-2 and 
IFN-3 are almost identical with 96% amino acid similarity (128) and thus they 
cannot be distinguished at mRNA or protein level by quantitative RT-PCR or 
ELISA, respectively. Of note, only IFN-1 could be measured at protein level (Fig. 
1B in III). To compare the ability of Salmonella and Sendai virus to induce IFN 
activity in host cells, human MxA protein expression was detected by Western 
blotting. Type I and type III IFNs (but not type II IFN) signaling induces the 
expression of MxA (132, 206). Salmonella elicited the production of MxA 
practically as efficiently as Sendai virus (Fig. 1C in III) confirming the ability of 
Salmonella to induce IFN response in DCs.  
 
To our knowledge, this is the first report showing that type III IFNs can be secreted 
by bacteria-infected DCs. Moreover, the mRNA induction of IFN-1, IFN-2/3, and 
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IFN- was not blocked by the presence of CHX, which was used to inhibit de novo 
protein synthesis (Fig. 2 in III) indicating that the mRNA induction is a direct 
consequence of interaction with bacteria. This is also supported by the rapid kinetics 
of IFN induction (Fig. 1A in III). Analyzing the effects of cell signaling inhibitors 
suggested that Salmonella-induced type I and type III IFN production requires p38 
MAPK, JNK MAPK, phosphoinositide 3-kinase, and NF-B pathways (Fig. 3 in III). 
  
Induction of type III IFNs and bacterial uptake are coupled 
 
Kagan et al. (204) recently demonstrated that inhibition of dynamin-dependent 
endocytosis by dynasore blocks LPS-induced TRAM-TRIF signaling in murine 
macrophages. Consequently, the production of cytokines such as IFN- was 
impaired (204). Dynasore is a small molecule inhibitor of the guanosine triphosphate 
hydrolysis activity of dynamin, which has been implicated in multiple forms of 
endocytosis (194, 207, 208). We analyzed the induction of cytokines in dynasore-
pretreated Salmonella-infected DCs and found that the mRNA expression and 
secretion of cytokines IFN-1, CXCL10, and IL-6 were greatly impaired compared 
to cells with mock-pretreatment (Fig. 5A-B in III). In the report by Kagan et al. 
(204), dynasore interfered with TLR4-mediated LPS endocytosis by inhibiting IRF3 
phosphorylation. Interestingly, we found that dynasore also inhibited the induction 
of CXCL10, and IL-6 when cells were stimulated with Streptococcus thermophilus, 
an innocuous Gram-positive bacterium (Fig. 5A-B in III). IFN-1 was not induced 
by Streptococcus thermophilus stimulation.  
 
Interestingly, dynasore did not block the production of IFN-1 in Sendai-virus 
infected cells (Fig. 5C in III), although dynasore inhibited the phosphorylation of 
IRF3 in response to Sendai virus infection (Fig. 5D in III). This can be explained by 
the fact that Sendai virus can enter cells without relying on endocytic pathways 
(209). In addition, other IRFs such as IRF7 could compensate for IRF3 in Sendai-
virus induced IFN-1 production. Dynasore also inhibited the Salmonella-induced 
phosphorylation of IRF3 (Fig. 5C in III), which is likely due to reduced uptake of  
live Salmonella by dynasore-pretreated DCs (Fig. 6 in III). As dynasore could also 
impair cytokine production in response to Streptococcus thermophilus (Fig. 5A-B in 
III), which lacks LPS, we hypothesize that dynasore is likely to interfere with 
pathways beyond TLR4 signaling. To define the specific endocytosis pathways 
operating in bacterial uptake in DCs, effector molecules necessary to different forms 
of endocytosis could be targeted by small interfering RNA approach or by using 
distinct chemical inhibitors.       
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Type I and type III IFNs may modulate functions of bacteria-infected DCs  
 
To date, no data is available on the role of type III IFNs in bacterial infection. 
Genetic ablation of IFNLR1, the unique receptor chain for type III IFNs, has 
confirmed the role of type III IFNs in antiviral immune responses (134, 135). 
However, considering that instead of three functional type III IFNs in humans, the 
mouse immune system is deficient in IFN-1 (129), these results should be 
interpreted with caution. Interestingly, type III IFNs have been shown to modulate 
cytokine secretion of immune cells and thus the guidance of T cell responses (136, 
138, 139).  
 
To address the role of type III IFNs in S. typhimurium -infected DCs, we treated 
cells for 20 h with purified preparations of human IFN- or IFN-1 after which DCs 
were left uninfected or infected with S. typhimurium. After 24 h, cell culture 
supernatants were analyzed for cytokine production and paraformaldehyde-fixed 
cells were stained with anti-CD86 or anti-HLA-II antibodies and analyzed by FACS. 
We found that both IFN- and IFN-1 treatment shifted the cytokine balance so that 
the production of IL-10 was enhanced and the production of IL-12 was decreased 
when compared to S. typhimurium infection alone (Fig. 4, unpublished). Meanwhile, 
pre-treatment of DCs with IFNs did not alter Salmonella-induced up-regulation of 
CD86 or HLA-II molecules (Fig. 4, unpublished). Along with the preliminary data 
presented here and other reports performed with human DCs (136, 138, 139), we 
speculate that type III IFNs may play a role in bacterial infection and influence the 
outcome of immune responses. IL-12 favors the differentiation of Th1 cells crucial 
in anti-Salmonella immunity. The production of IL-12 is potently inhibited by IL-10 
(18), which has anti-inflammatory properties. Although highly speculative, type III 
IFNs produced by DCs may act in an autocrine or paracrine fashion and shift the 
cytokine balance of IL-12 and IL-10 towards IL-10 thus guiding protective Th1 
responses (in the case of Salmonella) to less favorable T cell responses.   
 
The role of DCs, with special reference to DC-derived cytokines, in Salmonella 
infection is depicted in Figure 5.  
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5.2 Transcriptional regulation of cytokine gene expression in 
DCs  
 
5.2.1 Multiple NF-B and IRF family transcription factors regulate the 
expression of CCL19 gene (II) 
 
Although the role of CCL19 in DC biology was clear (see section 5.1.2), limited 
data on the control of the CCL19 gene expression was available creating a demand 
for a more detailed analysis of its regulation. Prior to our study, the activation of 
RelB/p52 dimer through alternative NF-B pathway had been implicated in the 
transcriptional control of CCL19 gene (210, 211). Moreover, a histone 
demethylation event on the CCL19 promoter had been shown to occur 
concomitantly with RNA polymerase II recruitment in LPS-stimulated DCs (212).   
 
As we had noted that the gene expression of CCL19 is induced in bacteria- or virus-
induced DCs (see section 5.1.2 and Fig. 1 in II), we decided to study the regulation 
mechanisms in detail. First, we employed pharmacological inhibitors targeting p38 
and ERK MAPKs, NF-B, and NFAT to study which signaling pathways are 
required for the production of CCL19 in DCs. Unfortunately, chemical inhibitors 
against IRFs were not commercially available. All the inhibitors reduced the mRNA 
expression of bacteria-induced CCL19 (Fig. 2 in II) at 9 h. At this time point, the 
inhibitors are likely to act in a specific manner; later time points studied showed 
inconsistent results (data not shown).    
 
Therefore, another approach was chosen: we characterized the human CCL19 
promoter region with computer programs identifying putative transcription factor 
binding sites. In particular, the proximal promoter was carefully analyzed for the 
presence of NF-B and ISRE sites (Fig. 3 in II). Two putative NF-B sites, NF-
B(1) at -62 to -52 and NF-B(2) at -363 to -354 nucleotides (relative to the 
transcription start site) were found. Further upstream at -851 to -842 nucleotides, 
ISRE consensus element was located. Based on this analysis, we constructed a 
luciferase reporter construct that would operate under the control of the CCL19 
promoter. The 1.5 kilobase promoter fragment contained the three putative 
transcription factor binding sites discussed above. In addition, promoter constructs 
with mutated consensus binding sites were created (Fig. 7A in II). Finally, the data 
was used to construct biotinylated oligonucleotides for DNA affinity binding assays. 
 
To test the functionality of the binding sites, we infected DCs with S. typhimurium 
or Sendai virus, and performed DNA affinity binding experiments with 
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oligonucleotides containing different consensus sequences derived from the CCL19 
promoter. Both NF-B elements were shown to recruit the binding of classical (p50 
and p65) and alternative (p52 and RelB) NF-B components (Fig. 4 in II). No c-Rel 
binding could be demonstrated. The components of alternative NF-B pathway are 
commonly activated by stimuli such as B cell activating factor, lymphotoxin , or 
CD40 ligand (158, 159), but in DCs, the activating signals have been shown to 
include TNF- or LPS (210, 211). Moreover, a previous study in a cell line 
suggested that live S. typhimurium or LPS induce the activation of p65, p50, c-Rel, 
and RelB in DCs (213). In conclusion, DCs can respond to various microbial or 
danger stimuli by activating the two, the classical and the alternative NF-B 
pathways. This allows the formation of distinct sets of NF-B dimers known to 
support a different amount of transcriptional activity (160).  
 
In the case of CCL19 ISRE element, we detected binding of multiple IRFs and 
STATs. Specifically, Salmonella induced the binding of IRF1, IRF3, IRF7, IRF9, 
STAT1, and STAT2 (Fig. 5B in II). Of these transcription factors, the protein 
expression level of IRF1, IRF7, IRF9, and STAT2 was increased in response to 
Salmonella infection (Fig. 5A in II). Compared to Salmonella, the kinetics of Sendai 
virus-induced binding was generally faster, and phosphorylated form of IRF3 could 
be easily detected (Fig. 5B in II). STAT1 and STAT2 together with IRF9 form an 
ISGF3 complex, which binds to ISRE sequences. However, using CCL19 ISRE 
oligonucleotide in electrophoretic mobility shift assay we failed to detect its 
formation in microbe-induced DCs (data not shown). Thus, the specific contribution 
of STATs to regulation of CCL19 remained unknown.   
 
The wild-type and mutant CCL19 promoter constructs were then used to transfect 
HEK-293 cells. The expression of p50/p65 or p52/RelB dimers could drive the 
transcriptional activity of CCL19 promoter (Fig. 7B in II). Of the NF-B elements, 
the proximal NF-B(1) seemed to be more important as the NF-B(2) site mutated 
on top of the mutated NF-B(1) did not further reduce the promoter activity (Fig. 7B 
in II). We also studied the role of IRFs in the activation of CCL19 promoter in a 
similar assay. IRF1, IRF3, and IRF7, whose binding to CCL19 ISRE had been 
demonstrated in response to Sendai virus infection (Fig. 5B in II), were transiently 
expressed in cells along with promoter constructs, after which Sendai virus was 
added in order to activate the IRFs. IRF1, IRF3, and IRF7, but not IRF5, could 
induce CCL19 promoter activity, which was inhibited by mutation of the ISRE site 
(Fig. 7C in II).  
 
To provide insight into the signaling pathways that could induce CCL19 promoter 
activation, we transfected cells with expression constructs for the upstream 
transcription factors. The components detecting the cytoplasmic presence of viruses, 
RIG-I and CARDIF, activated CCL19 promoter transcription (Fig. 8 in II). 
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Moreover, MyD88 and TRIF, that transmit MyD88-dependent and MyD88-
independent signaling, respectively, also mediated transcriptional activity. TLR- and 
RIG-I -mediated signaling are known to converge at the level of TBK1/IKK(57-
60), and so, overexpression of TBK1 or IKK could consistently promote CCL19 
promoter activation (Fig. 8 in II).  
 
Taken together, the transcriptional activation of the human CCL19 gene requires 
concerted action of many transcription factors including both classical and 
alternative NF-B components, IRFs, and most likely STATs. Our results 
demonstrating the importance of NF-B in the activation of CCL19 gene were 
consistent with previous studies (210, 211). Moreover, a very recent report by 
Gasparini et al. (214) has suggested that in mature DCs, RelB is only active when it 
dimerizes with p50 (instead of p52). With a very elegant approach using adenoviral 
vectors expressing RelB or p50, the authors showed that RelB/p50 preferentially 
induces CCL19, but not other cytokines and chemokines. The authors further 
speculated that the NF-B(1) site analyzed in this study (II), may in fact bind 
RelB/p50 dimers (214). Indeed, this seems possible considering that preferential 
activation of RelB/p50 complexes in mature human DCs has been previously 
reported (213, 215).   
 
5.2.2 The regulation type I and type III IFN genes – common 
mechanisms underlying (IV) 
 
Type I IFN production is mainly controlled at the transcriptional level (95). For the 
most part, the biological activities such as antiviral host defenses induced by type I 
IFNs are shared with type III IFNs (127, 128, 132, 134, 135) – this led us to 
elucidate the common and disparate mechanisms involved in the transcriptional 
regulation of type III IFN versus type I IFN genes.  
 
The experimental system to study the regulation of IFN genes was Sendai virus-
infected human DCs where robust type I IFN and type III IFN gene expression 
occurs (Fig. 1 in III) (132). Of note, the expression of IFN-1 and IFN- mRNAs 
appeared earlier than those of IFN-2/3 and IFN-1 mRNAs (Fig. 1 in III). By using 
the promoter structure of IFN- as a reference point, we again used computer 
programs to identify putative binding sites for IRFs and NF-B on type III IFN 
genes. The proximal IFN-1 promoter contained at least two ISRE/PRD and two 
NF-B elements, whereas only one NF-B and two ISRE/PRD sites were located in 
the promoter region of IFN-2/3 (Fig. 2 in III and Fig. 6). We tested the 
functionality of these promoter elements by DNA affinity binding assay, and 
detected virus-inducible binding of p65, p50, and RelB or IRF1, IRF3 and IRF7 to 
 THL  – Research 27/2009 57 
Microbe-induced Innate 
Immune Responses in Human 
Dendritic Cells 
 
the NF-B or ISRE/PRD sites, respectively (Fig. 3 in III). The binding of IRF8 or 
p52 remained unchanged in virus stimulation. Previous work in our laboratory had 
demonstrated that the two distal elements on the IFN-1 promoter studied here, 
ISRE and NF-B2, were functional in influenza virus-infected DCs (132). 
Simultaneously with us Onoguchi et al. (216) had described a set of putative IRF 
and NF-B binding sites present in human type III IFN promoters. Using HeLa cells, 
they showed by electrophoretic mobility shift assay that p50/p65 dimers could bind 
to NF-B site of IFN-1 (216); this site corresponds to NF-B1 element described 
by us (Fig. 3 in III).  
 
 
 
Similar to studying the regulation of CCL19, we constructed promoter fragments of 
IFN-1 and IFN-3 carrying the crucial cis-acting elements and compared their 
activation to much studied IFN- and IFN- promoters. First, we focused on IRF1, 
IRF3, IRF5, IRF7, and IRF8, which are known to positively regulate type I IFN 
gene induction (95). The differential role of IRFs was revealed by transfection 
assays in HEK-293 cells. Sendai virus infection greatly increased the promoter 
activities of IFN-1 and IFN-this was induced even more by the concomitant 
expression of IRF1, IRF3, or IRF7 (Fig. 4A in III). By contrast, the activation of 
IFN-3 promoter followed the pattern of IFN- promoters. Sendai virus infection 
promoted weak activation of IFN-3, IFN-1, and IFN-4 promoters, IRF7 being 
superior to IRF1 or IRF3 at multiplying this effect (Fig. 4A in III). These findings 
are in agreement with Onoguchi et al. (216) who showed that IRF3 is more efficient 
at inducing IFN-1 than IFN-3 promoter activity. Although IRF5 could induce 
IFN-or IFN-1 promoter activity, it did not promote the activation of IFN-3 or 
IFN-s (Fig. 4A in III). Indeed, preferential promoter activation of IFN- but not 
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those of IFN-s, was driven by IRF5 in a similar experimental setting to ours (150). 
Interestingly, the presence of IRF8 did not increase virus-induced promoter 
activities (Fig. 4A in III), in effect, IRF8 could down-regulate IRF7-mediated 
promoter activity by altering the stability of IRF7 (Fig. 5 in III). As IRF8 has been 
ascribed a positive role in regulating type I gene expression in the mouse system 
(155, 156), our results may be indicative of certain species-specific differences in 
IFN gene regulation.  
 
We also analyzed whether overexpression of NF-B components could stimulate 
IFN promoters. IFN- promoters were not sensitive to p50/p65 expression, whereas 
the promoters of IFN-1, IFN-3, and IFN- were greatly induced reflecting the 
absence and presence of NF-B elements in the promoter regions, respectively (Fig. 
4B in III). Our data suggests that multiple IRF and NF-B factors can activate type 
III IFN gene expression. Consistently, Onoguchi et al. (216) reported that mutation 
of NF-B and IRF binding sites of IFN-1 promoter (corresponding to NF-B1 and 
ISRE) impaired viral-induced gene activity, and the effect was more pronounced 
when both sites were simultaneously disrupted.    
 
Finally, to identify which signaling pathways emanating from pathogen detection 
could regulate type III IFN expression, we overexpressed molecules involved in 
TLR and RIG-I signaling. Again, similarities between IFN-1 and IFN- or IFN-3 
and IFN-s were detected. RIG-I, CARDIF, IKK, TBK1, and TRIF promoted 
higher activation of IFN-1 and IFN- than of IFN-3 and IFN- promoters (Fig. 6 
in III). The role of CARDIF, RIG-I, and TBK1 in the induction of type III IFNs had 
already been suggested by Onoguchi et al. (216). MyD88 serves as a signaling 
adaptor molecule for type I IFN induction by TLR7, TLR8, and TLR9 (44). Further, 
MyD88 can interact with IRF1, IRF5, and IRF7, which is required for gene 
induction (44). Thus, we mimicked TLR7/8 ligation by combining MyD88 
expression construct with above IRFs in the presence of Sendai virus infection. 
MyD88 alone could induce only a moderate activation of IFN- promoters (Fig. 6B 
in III). The combination of MyD88 and IRF7 was the only good stimulus for 
activating IFN-3 and IFN-s, whereas IFN-1 and IFN- were highly responsive 
when MyD88 was combined with IRF1 or IRF7. Although IFN-4 and IFN- 
promoters were responsive, IFN-1, IFN-3, and IFN-1 promoter activities were 
not induced by MyD88 and IRF5. Thus, we concluded that multiple signaling 
pathways can lead to type III IFN expression. Specifically, RLR-, TLR3-, and 
TLR7/8-mediated signaling coinciding at the level of TBK1 and IKK could lead to 
induction of type III IFNs. 
 
In addition to the IRF and NF-B binding sites, the promoter region of type III IFN 
is likely to contain additional regulatory elements. This is suggested by observations 
in Salmonella-infected DCs where the induction of IFN-1 or IFN-3 mRNA was 
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most efficiently blocked by p38 MAPK inhibitor and to a lesser extent by PI3 kinase 
inhibitor (Fig. 3A in IV). The IFN-1 protein level was also reduced by JNK MAPK 
inhibitor (Fig. 3B in IV). Likewise, inhibition of p38 MAPK in Sendai virus infected 
DCs impairs the induction of type III IFN genes (data not shown). Interestingly, 
Thomson et al. (217) demonstrated in their very recent work that the human IFN-1 
promoter contains four distal NF-B elements originating from transposition events 
in addition to the two proximal NF-B sites used by us. These newly described NF-
B elements together with ISRE were found to be crucial for IFN-1 induction in 
LPS-stimulated DCs (217); whether this applies to other stimuli remains unknown.  
 
In conclusion, the regulation of type III IFN genes is reminiscent of type I IFN gene 
system where coordinate activation of transcription factors such as NF-B, AP-1, 
and IRFs leads to gene induction. Moreover, similarities between the expression 
kinetics, the magnitude of induction, as well as selectivity in transcription factor 
usage suggest that the regulation of IFN-1 and IFN-2/3 resembles the control of 
IFN- and IFN- genes, respectively. 
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6 Concluding remarks 
Upon contact with a microbe, several phenomena including microbial phagocytosis 
and cytokine production are activated in APCs. The signals leading to the cytokine 
production are transmitted from PRRs that recognize genetic material and/or 
structural components of microbes. Macrophages and DCs share the ability to sense 
surrounding microbes and produce cytokines that regulate both innate and adaptive 
immune responses. Macrophages operate mainly locally by ingesting and destroying 
microbial pathogens, whereas DCs, after contacting a pathogen, undergo a process 
of maturation. The mission of mature DCs is to migrate to local lymph nodes and 
present antigens to naïve T cells.  
 
This study addressed the activation of innate immune responses primarily in DCs 
infected with S. typhimurium. One of the major findings was that S. typhimurium 
could survive in intracellular compartments of human DCs much like in 
macrophages. We also found that DCs undergo an efficient maturation process in 
response to S. typhimurium infection or stimulation of cells with bacterial 
components. S. typhimurium-infected macrophages and DCs also produce multiple 
cytokines including IFN-, CCL19 and CCL20, as well as type I and novel type III 
IFNs.  
 
Another main focus of the work was to provide insight into the regulation of CCL19 
and type III IFN genes. Many levels of regulation ensure the control of cytokine 
gene expression; we chose to focus on the transcriptional regulation of these genes. 
As a common theme, we observed that the regulation of CCL19 and type III IFNs is 
elicited by simultaneous and coordinate activation of many signaling pathways. 
While CCL19 was preferentially regulated by NF-B, IRF transcription factors had 
a significant positive regulatory role. In the case of type III IFN genes, IRF3, IRF7 
as well as NF-B, seemed to play a major role in regulating their expression, which 
was reminiscent of type I IFN regulation.  
 
In addition, we found that type III IFNs are produced not only upon virus infection 
but also in response to bacterial stimulation in human DCs. These type III IFNs may 
modulate the function of other immune cells. The fundamental differences of the 
type III IFN system between human and mouse warrant further research in this field 
not only in vitro but also in vivo. It is tempting to speculate that by analogy to 
production of type I IFNs that can confer harmful or beneficial effects to the host, 
also type III IFNs may exhibit this dual role in vivo depending on the infecting 
microbe.  
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Recent decade has witnessed the expansion in our knowledge of host innate immune 
responses. Understanding the complex signal cascades induced by microbial stimuli 
and accumulating data of co-operativity of different signaling pathways will provide 
us a more comprehensive background for development of novel vaccines and 
pharmaceuticals to treat infections and control host inflammatory responses.   
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Multiple NF-B and IFN Regulatory Factor Family
Transcription Factors Regulate CCL19 Gene Expression
in Human Monocyte-Derived Dendritic Cells1
Taija E. Pietila¨,2* Ville Veckman,* Anne Lehtonen,† Rongtuan Lin,‡ John Hiscott,‡
and Ilkka Julkunen*
CCL19 chemokine has a central role in dendritic cell (DC) biology regulating DC traffic and recruitment of naive T cells to the
vicinity of activated DCs. In this study, we have analyzed the regulation of CCL19 gene expression in human monocyte-derived
DCs. DCs infected with Salmonella enterica or Sendai virus produced CCL19 at late times of infection. The CCL19 promoter was
identified as having two putative NF-B binding sites and one IFN-stimulated response element (ISRE). Transcription factor
binding experiments demonstrated that Salmonella or Sendai virus infection increased the binding of classical p50p65 and
alternative p52RelB NF-B proteins to both of the CCL19 promoter NF-B elements. Interestingly, Salmonella or Sendai virus
infection also increased the binding of multiple IFN regulatory factors (IRFs), STAT1, and STAT2, to the ISRE element. Enhanced
binding of IRF1, IRF3, IRF7, and IRF9 to the CCL19 promoter ISRE site was detected in Salmonella or Sendai virus-infected cell
extracts. The CCL19 promoter in a luciferase reporter construct was activated by the expression of NF-B p50p65 or p52RelB
dimers. IRF1, IRF3, and IRF7 proteins also activated CCL19 promoter in the presence of Sendai virus infection. CCL19 promoter
constructs mutated at NF-B and/or ISRE sites were only weakly activated. Ectopic expression of RIG-I (RIG-I, CARDIF) or
TLR3/4 (TRIF, MyD88, IKK, or TBK1) signaling pathway components induced CCL19 promoter activity, suggesting that these
pathways are important in CCL19 gene expression. Our experiments reveal that expression of the CCL19 gene is regulated by a
combined action of several members of the NF-B, IRF, and STAT family transcription factors. The Journal of Immunology,
2007, 178: 253–261.
D endritic cells (DCs)3 are professional APCs that reside inperipheral tissues where they are on alert for emergingpathogens. DCs regulate the activation of both innate
and adaptive immune responses, and their role during microbial
infections is well recognized. Upon contact with a microbe, they
undergo a maturation process that is associated with enhanced ex-
pression of Ag presenting and costimulatory molecules and the
production of cytokines and chemokines. Eventually, DCs migrate
to a local lymph nodes where Ag presentation to naive T cells
takes place (1).
DC trafficking is tightly controlled by differential expression of
chemokine ligands and chemokine receptors. Immature DCs ex-
press CCR6 and respond to its exclusive ligand CCL20 (2). How-
ever, maturation of DCs leads to down-regulation of CCR6 and
thus loss of their responsiveness to CCL20. At the same time,
mature DCs gain responsiveness to CCL19 via induced CCR7 ex-
pression (2, 3). DCs eventually migrate to T cell zones of local
lymph nodes where T lymphocytes are also recruited by the effect
of chemokines. CCL19, and the other ligand of CCR7, CCL21, are
both expressed by stromal cells in the T cell zone of the lymph nodes
(4). Mice deficient in CCL19 and CCL21 or CCR7 display defective
DC traffic and impaired immune responses (5–7). Because DCs are
also capable of producing both CCL19 and CCL20, it is evident that
these chemokines have a unique role in DC biology.
Transcription of cytokine and chemokine genes requires the
controlled action of multiple transcription factors activated by mi-
crobes or their structural components. Activated transcription fac-
tors bind to the regulatory elements of cytokine/chemokine genes,
and may either repress or activate the transcription of the respec-
tive gene. Mammalian NF-B/Rel family has five members; NF-
B1 (p50), NF-B2 (p52), RelA (p65), RelB, and c-Rel. NF-B
plays an important role in the regulation of innate immunity by
activating a wide variety of immune response genes, such as proin-
flammatory cytokines and chemokines, and cell adhesion mole-
cules (8–10). NF-B proteins form various homo- or heterodimers
that bind to specific NF-B recognition sites located in the regu-
latory regions of many genes (10).
IFN regulatory factors (IRFs) constitute a family of nine
(IRF1–9) transcription factors that bind to a specific DNA motif
known as the IFN-stimulated response element (ISRE) (11).
Among IRF family members, IRF1, IRF3, and IRF7 have been
established as essential factors for chemokine gene expression
in response to viral or cytokine stimulation (12–16). Recently,
IRF5 has also been implicated in the regulation of cytokine and
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IFN Regulatory Factor Family Members Differentially
Regulate the Expression of Type III IFN (IFN-) Genes1
Pamela I. O¨ sterlund,2* Taija E. Pietila¨,* Ville Veckman,* Sergei V. Kotenko,†
and Ilkka Julkunen*
Virus replication induces the expression of antiviral type I (IFN-) and type III (IFN-1–3 or IL-28A/B and IL-29) IFN genes
via TLR-dependent and -independent pathways. Although type III IFNs differ genetically from type I IFNs, their similar biological
antiviral functions suggest that their expression is regulated in a similar fashion. Structural and functional characterization of the
IFN-1 and IFN-3 gene promoters revealed them to be similar to IFN- and IFN- genes, respectively. Both of these promoters
had functional IFN-stimulated response element and NF-B binding sites. The binding of IFN regulatory factors (IRF) to type III
IFN promoter IFN-stimulated response element sites was the most important event regulating the expression of these genes.
Ectopic expression of the components of TLR7 (MyD88 plus IRF1/IRF7), TLR3 (Toll/IL-1R domain-containing adapter-inducing
factor), or retinoic acid-inducible gene I (RIG-I) signal transduction pathways induced the activation of IFN-1 promoter, whereas
the IFN-3 promoter was efficiently activated only by overexpression of MyD88 and IRF7. The ectopic expression of Pin1, a
recently identified suppressor for IRF3-dependent antiviral response, decreased the IFN promoter activation induced by any of
these three signal transduction pathways, including the MyD88-dependent one. To conclude, the data suggest that the IFN-1 gene
is regulated by virus-activated IRF3 and IRF7, thus resembling that of the IFN- gene, whereas IFN-2/3 gene expression is
mainly controlled by IRF7, thus resembling those of IFN- genes. The Journal of Immunology, 2007, 179: 3434–3442.
O ne of the major cellular responses to virus infection isthe synthesis of antiviral cytokines, IFNs. Type I IFNs(IFN-) are the classical antiviral IFNs, but recently, a
novel class of antiviral cytokines was discovered and classified as
type III IFNs (IFN-1/IL-29, IFN-2/IL-28A, IFN-3/IL-28B) (1,
2). These two types of IFNs, which display similar antiviral ac-
tivities (1–4), have evolved separately and are only distantly re-
lated to each other. IFNs induce the expression of several antiviral
proteins, such as dsRNA-activated protein kinase R, oligoadeny-
late synthetases, and Mx proteins, which ultimately mediate the
antiviral actions of IFNs (5). In addition to the direct antiviral
action, IFNs have many immunoregulatory functions. They can
induce the expression of several cytokine and chemokine genes
and prime cells for enhanced virus-induced production of IFNs and
other cytokines. However, the main function of IFNs is likely to be
the ability to inhibit virus replication in virus-infected cells and to
protect uninfected cells from virus infection. Type I IFN induction
is mainly regulated by IFN regulatory factor (IRF)3 3 and IRF7 (6,
7). IRF3 is expressed constitutively, whereas IRF7 is an IFN-stim-
ulated gene and often induced at later phases of virus infection. It
has been shown that IRF3 regulates the expression of IFN- gene
rather than IFN- genes, whereas IRF7 activates both the late-
phase IFN- and IFN- gene expression (6, 8, 9). Thus, the in-
duction of IRF7 in response to IFNs and its activation after viral
infection provide a positive feedback for the production of IFNs
(6). Very recently, it was reported by Honda et al. (10) that in
IRF7-deficient mice IFN induction is more severely impaired as
compared with that in IRF3-deficient mice. IRF7 was suggested to
play a major role in IFN induction even in the absence of IRF3,
whereas IRF3-mediated IFN induction remains minimal without
the presence of even low amounts of IRF7. In the mouse, IRF8 has
also been suggested to positively regulate the later phase of type I
IFN induction (11).
In viral infections, innate immune responses are initiated when
viruses or their genetic material are recognized by cellular pattern
recognition receptors such as TLRs. This leads to the activation of
several transcription factor systems that are involved in the regu-
lation of chemokine and cytokine gene expression. Recently, it
was shown that the recognition of viral ssRNA, including that of
influenza A virus, is mediated via TLR7. Thus, TLR7 seems to
play an important role in the induction of antiviral responses
against RNA viruses (12–14). TLR7 activation signal is transduced
via MyD88 to the IL-1R-associated kinase 1/4 complex that acti-
vates IRF7 by a specific phosphorylation event. The TLR7 path-
way is active, especially in plasmacytoid dendritic cells (DCs),
which are responsible for the production of high levels of IFN-
(15). Viral dsRNA is also formed during the replication cycle of a
virus and it is recognized by TLR3. TLR3 signaling takes place via
the Toll/IL-1R domain-containing adapter-inducing IFN- (TRIF)
adapter molecule, leading to the activation of IB kinase (IKK) 
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